Category	Term	Count	%	PValue	Genes	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
KEGG_PATHWAY	hsa04115:p53 signaling pathway	62	98.4126984126984	2.534075657865813E-141	STEAP3, ZMAT3, RPRM, PMAIP1, PTEN, GTSE1, CCNE2, CCNE1, CASP3, TP53I3, CDKN2A, CASP9, CASP8, SERPINE1, FAS, CYCS, TP53, CDK6, CDK4, CDK2, RFWD2, PPM1D, CCND1, CCND3, SERPINB5, CCND2, RRM2, CD82, GADD45G, DDB2, MDM2, SIAH1, MDM4, GADD45B, GADD45A, BID, CHEK1, RRM2B, CHEK2, SFN, CCNG1, SESN2, CCNG2, SESN1, SESN3, RCHY1, THBS1, IGF1, ATR, TP73, ATM, CCNB1, CCNB3, CDKN1A, EI24, CCNB2, BBC3, BAX, TSC2, APAF1, PERP, IGFBP3	63	67	6910	101.49727552712628	2.6861201973377617E-139	2.6861201973377617E-139	2.843491240576953E-138
GAD_DISEASE	esophageal adenocarcinoma	28	44.44444444444444	1.1364851417930601E-27	BID, CHEK1, CHEK2, PTEN, CCNE1, TP53I3, CASP3, CDKN2A, CASP9, CASP8, FAS, THBS1, TP53, IGF1, CDK6, ATR, CDK4, ATM, CCNB1, CDKN1A, CCND1, CCND3, BAX, TSC2, MDM2, APAF1, PERP, IGFBP3	58	351	12971	17.840062874545634	1.3092308833456052E-24	1.3092308833456052E-24	1.8279849134590235E-24
KEGG_PATHWAY	hsa04110:Cell cycle	23	36.507936507936506	1.0387914756511666E-23	TP53, CHEK1, CDK6, SFN, ATR, CHEK2, CDK4, CDK2, ATM, CCNE2, CCNB1, CCNE1, CCNB3, CCND1, CDKN1A, CCNB2, CDKN2A, CCND3, CCND2, GADD45G, MDM2, GADD45B, GADD45A	63	124	6910	20.344342037890424	1.1011189641902366E-21	5.505594820951183E-22	1.1656299418809664E-20
GAD_DISEASE	ovarian cancer	24	38.095238095238095	3.1549855812055536E-21	TP53, IGF1, CDK6, CHEK2, CCNG1, CDK4, CCNG2, PTEN, CDK2, CCNE2, CCNB1, CCNE1, CCND1, CDKN1A, CCNB2, CDKN2A, CCND3, CCND2, CASP8, SERPINE1, MDM2, FAS, MDM4, IGFBP3	58	370	12971	14.506244175209693	3.634543389548798E-18	1.817271694774399E-18	5.074651513283619E-18
UP_KEYWORDS	Apoptosis	24	38.095238095238095	5.0801540419134224E-21	BID, STEAP3, ZMAT3, CYCS, TP53, CHEK2, PMAIP1, PTEN, TP73, EI24, CASP3, TNFRSF10B, CDKN2A, CASP9, BBC3, BAX, GADD45G, CASP8, SIAH1, FAS, APAF1, PERP, GADD45B, IGFBP3	63	536	20581	14.627576403695807	6.096184850296107E-19	6.096184850296107E-19	5.8316726419110285E-18
UP_KEYWORDS	Cyclin	12	19.047619047619047	1.5593557875157272E-19	CCNB1, CCNE2, CCNE1, CCNB3, CCND1, CDKN2A, CCNB2, CCND3, CCND2, CCNG1, CDK4, CCNG2	63	40	20581	98.00476190476189	1.8712269450188725E-17	9.356134725094363E-18	1.7900347922591733E-16
GAD_DISEASE	breast cancer   	25	39.682539682539684	3.3490757898438064E-19	BID, TP53, IGF1, CHEK1, CDK6, CHEK2, ATR, CDK4, PTEN, TP73, CDK2, ATM, CCNE1, CCND1, CDKN1A, TNFRSF10B, CDKN2A, CCND3, CCND2, CASP8, MDM2, FAS, MDM4, IGFBP3, GADD45A	58	518	12971	10.793336439888163	3.858135309900065E-16	1.2860451033000217E-16	5.386836829389972E-16
UP_KEYWORDS	Cell cycle	24	38.095238095238095	3.735063366058803E-19	STEAP3, TP53, CHEK1, CDK6, CHEK2, CCNG1, CDK4, CCNG2, CDK2, ATM, TP73, CCNE2, CCNB1, CCNE1, PPM1D, CCNB3, CCND1, CDKN1A, CCNB2, CDKN2A, CCND3, CCND2, SIAH1, GADD45A	63	650	20581	12.062124542124542	4.482076039270564E-17	1.4940253464235214E-17	4.2875996806280403E-16
GAD_DISEASE	epithelial ovarian cancer 	18	28.57142857142857	3.80802946098265E-19	TP53, IGF1, CHEK1, ATR, CHEK2, PTEN, ATM, CCNE1, TP53I3, CDKN1A, CCND1, CDKN2A, GADD45G, DDB2, MDM2, GADD45B, IGFBP3, GADD45A	58	170	12971	23.679310344827588	4.386849939052013E-16	1.0967124847630032E-16	6.125043037255384E-16
GAD_DISEASE	Brain Neoplasms|Glioma|meningioma|Neuroma, Acoustic|Neuromas, Acoustic	9	14.285714285714285	3.721445261061286E-18	CDKN1A, CCND1, CDKN2A, CASP8, TP53, MDM2, CHEK1, CHEK2, PTEN	58	10	12971	201.2741379310345	4.287104940742601E-15	8.574209881485202E-16	5.9857762704673384E-15
GAD_DISEASE	lung cancer 	24	38.095238095238095	5.445778562895233E-18	TP53, IGF1, CHEK1, ATR, CHEK2, CDK4, PTEN, TP73, ATM, TP53I3, CASP3, CCND1, CDKN1A, CDKN2A, CCND3, CASP9, BAX, CASP8, SERPINE1, MDM2, FAS, APAF1, IGFBP3, GADD45A	58	516	12971	10.40176423416199	6.2735369044553084E-15	1.0455894840758847E-15	8.7592883434491E-15
GAD_DISEASE	Breast Cancer	25	39.682539682539684	9.14560924621263E-18	TP53, IGF1, CHEK1, CDK6, CHEK2, ATR, CDK4, PTEN, TP73, CDK2, ATM, CCNB1, CCNE1, CCND1, CDKN1A, CDKN2A, CCND3, CCND2, CASP8, SERPINE1, DDB2, MDM2, FAS, MDM4, IGFBP3	58	598	12971	9.349411832545266	1.053574185163695E-14	1.5051059788052787E-15	1.471029854388733E-14
GAD_DISEASE	Bladder Cancer	24	38.095238095238095	9.430719234935865E-18	TP53, IGF1, CHEK1, CDK6, CHEK2, CDK4, PTEN, ATM, CCNE1, TP53I3, CASP3, CCND1, CDKN1A, CDKN2A, CCND3, CASP9, BAX, CASP8, TSC2, DDB2, MDM2, FAS, APAF1, IGFBP3	58	529	12971	10.146144319144774	1.0864188558646116E-14	1.3580235698307646E-15	1.516888505672134E-14
GAD_DISEASE	Colorectal Cancer	22	34.92063492063492	2.92414785776799E-17	BID, TP53, RPRM, IGF1, CHEK1, RRM2B, CHEK2, PTEN, ATM, TP73, CASP3, CDKN1A, CCND1, TNFRSF10B, CDKN2A, CASP9, CASP8, SERPINE1, MDM2, FAS, THBS1, IGFBP3	58	426	12971	11.549376720090658	3.368618332148724E-14	3.742909257943027E-15	4.7033594828085486E-14
GAD_DISEASE_CLASS	CANCER	45	71.42857142857143	8.911383277559511E-17	BID, RPRM, CHEK1, CHEK2, RRM2B, SFN, CCNG1, CCNG2, PTEN, CCNE2, CCNE1, CASP3, TP53I3, CDKN2A, CASP9, CASP8, SERPINE1, FAS, THBS1, TP53, IGF1, CDK6, ATR, CDK4, TP73, ATM, CDK2, CCNB1, CCND1, CDKN1A, TNFRSF10B, CCNB2, CCND3, CCND2, BAX, TSC2, GADD45G, DDB2, MDM2, APAF1, MDM4, GADD45B, PERP, GADD45A, IGFBP3	58	3197	12971	3.147859523475672	1.9984014443252818E-15	1.9984014443252818E-15	7.771561172376096E-14
GAD_DISEASE	Lung Cancer	24	38.095238095238095	1.153738500023007E-16	TP53, IGF1, CHEK1, RRM2B, ATR, CHEK2, CDK4, PTEN, TP73, ATM, TP53I3, CASP3, CCND1, CDKN1A, CDKN2A, CCND3, CASP9, BAX, CASP8, DDB2, MDM2, FAS, APAF1, IGFBP3	58	593	12971	9.051113566319707	1.2789769243681803E-13	1.27675647831893E-14	1.7763568394002505E-13
GOTERM_BP_DIRECT	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	12	19.047619047619047	2.9588674682058744E-16	CCNB1, CDKN1A, BAX, TP53, MDM2, CHEK2, MDM4, SFN, GADD45A, ATM, GTSE1, CDK2	63	62	16792	51.588325652841775	2.701172618913006E-13	2.701172618913006E-13	5.10702591327572E-13
INTERPRO	IPR006671:Cyclin, N-terminal	10	15.873015873015872	1.0074562215656537E-15	CCNB1, CCNE2, CCNE1, CCNB3, CCND1, CCNB2, CCND3, CCND2, CCNG1, CCNG2	61	34	18559	89.48408871745418	1.538769112130467E-13	1.538769112130467E-13	1.199040866595169E-12
GOTERM_BP_DIRECT	GO:0042981~regulation of apoptotic process	16	25.396825396825395	1.1450347341067165E-15	BID, STEAP3, TP53, PMAIP1, ATM, TP73, TP53I3, TNFRSF10B, CASP9, BBC3, BAX, CASP8, APAF1, FAS, PERP, IGFBP3	63	213	16792	20.021760190774273	9.00390872971002E-13	4.50195436485501E-13	1.709743457922741E-12
GAD_DISEASE	ovarian cancer  	15	23.809523809523807	1.245228835465907E-15	CCNE1, CCND1, CDKN1A, CDKN2A, CCND3, CCND2, CASP8, SERPINE1, TP53, IGF1, CHEK2, CDK4, IGFBP3, ATM, CDK2	58	145	12971	23.134958382877528	1.4068746168049984E-12	1.2789769243681803E-13	1.965094753586527E-12
SMART	SM00385:CYCLIN	10	15.873015873015872	2.8515992152782618E-15	CCNB1, CCNE2, CCNE1, CCNB3, CCND1, CCNB2, CCND3, CCND2, CCNG1, CCNG2	37	36	10057	75.503003003003	9.237055564881302E-14	9.237055564881302E-14	2.4980018054066022E-12
INTERPRO	IPR013763:Cyclin-like	10	15.873015873015872	1.3357434647754073E-14	CCNB1, CCNE2, CCNE1, CCNB3, CCND1, CCNB2, CCND3, CCND2, CCNG1, CCNG2	61	44	18559	69.1467958271237	2.0516921495072893E-12	1.0258460747536446E-12	1.5987211554602254E-11
GOTERM_CC_DIRECT	GO:0000307~cyclin-dependent protein kinase holoenzyme complex	8	12.698412698412698	2.3459106862745266E-14	CCNE1, CDKN1A, CCND1, CCND3, CCND2, CDK6, CDK4, CDK2	63	15	18224	154.27724867724868	2.857936109990078E-12	2.857936109990078E-12	2.6967317268145052E-11
GOTERM_MF_DIRECT	GO:0005515~protein binding	58	92.06349206349206	2.5521677975803663E-14	STEAP3, ZMAT3, RPRM, PMAIP1, PTEN, GTSE1, CCNE2, CCNE1, CASP3, CDKN2A, CASP9, CASP8, SERPINE1, FAS, CYCS, TP53, CDK6, CDK4, CDK2, RFWD2, PPM1D, CCND1, TNFRSF10B, CCND3, SERPINB5, CCND2, RRM2, CD82, GADD45G, DDB2, MDM2, SIAH1, MDM4, GADD45B, GADD45A, BID, CHEK1, CHEK2, SFN, RRM2B, CCNG1, SESN2, SESN1, RCHY1, THBS1, IGF1, ATR, TP73, ATM, CCNB1, CCNB3, CDKN1A, CCNB2, BBC3, BAX, TSC2, APAF1, IGFBP3	60	8785	16881	1.8575184974388161	4.136690989753333E-12	4.136690989753333E-12	3.0897506775318107E-11
BIOCARTA	h_p53Pathway:p53 Signaling Pathway	11	17.46031746031746	6.738497599623374E-14	CCNE1, CDKN1A, CCND1, BAX, TP53, MDM2, APAF1, CDK4, GADD45A, ATM, CDK2	35	17	1625	30.04201680672269	5.121680857200772E-12	5.121680857200772E-12	7.090994458280875E-11
KEGG_PATHWAY	hsa05161:Hepatitis B	17	26.984126984126984	7.342639444771523E-14	CYCS, TP53, CDK6, CDK4, PTEN, CDK2, CCNE2, CCNE1, CDKN1A, CCND1, CASP3, CASP9, BAX, CASP8, DDB2, FAS, APAF1	63	145	6910	12.859332238642581	7.778888644338622E-12	2.592925874012053E-12	8.234524173644786E-11
INTERPRO	IPR004367:Cyclin, C-terminal domain	8	12.698412698412698	7.95729485681954E-14	CCNB1, CCNE2, CCNE1, CCNB3, CCND1, CCNB2, CCND3, CCND2	61	18	18559	135.22040072859744	1.2258860593306053E-11	4.086286864435351E-12	9.549028234800971E-11
GOTERM_BP_DIRECT	GO:0006915~apoptotic process	20	31.746031746031743	9.043344315762118E-14	STEAP3, TP53, PMAIP1, PTEN, TP73, EI24, CASP3, TNFRSF10B, CDKN2A, CASP9, BBC3, BAX, GADD45G, CASP8, SIAH1, FAS, APAF1, GADD45B, IGFBP3, GADD45A	63	567	16792	9.401752470535538	7.338185614713666E-11	2.4460655723146374E-11	1.3914425167627087E-10
SMART	SM01332:SM01332	8	12.698412698412698	1.2534543269336472E-13	CCNB1, CCNE2, CCNE1, CCNB3, CCND1, CCNB2, CCND3, CCND2	37	18	10057	120.8048048048048	4.0110137433657655E-12	2.0055068716828828E-12	1.0855760734784781E-10
GOTERM_BP_DIRECT	GO:0043065~positive regulation of apoptotic process	16	25.396825396825395	1.8604259319190877E-13	BID, ZMAT3, TP53, PMAIP1, CDK4, ATM, TP73, CDKN2A, BAX, GADD45G, SIAH1, APAF1, FAS, GADD45B, IGFBP3, GADD45A	63	300	16792	14.215449735449734	1.5090551030993993E-10	3.772637757748498E-11	2.861377801366416E-10
GOTERM_BP_DIRECT	GO:0051726~regulation of cell cycle	12	19.047619047619047	8.386158142637064E-13	CCNB1, CCNE2, CCNE1, CCNB2, TSC2, GADD45G, GADD45B, CCNG1, PTEN, CCNG2, GADD45A, ATM	63	124	16792	25.794162826420887	6.801552654422949E-10	1.3603107529291947E-10	1.2896572698650743E-9
GAD_DISEASE	Chronic renal failure|Kidney Failure, Chronic	24	38.095238095238095	1.0465361156115022E-12	BID, TP53, IGF1, CHEK1, CDK6, ATR, CHEK2, CDK4, CDK2, ATM, CASP3, CCND1, CDKN1A, CDKN2A, CCND3, CASP9, CCND2, BAX, GADD45G, SERPINE1, MDM2, FAS, THBS1, IGFBP3	58	905	12971	5.9307296627929125	1.2055636489094468E-9	1.0046363740912057E-10	1.6832424343249386E-9
GAD_DISEASE	chronic obstructive pulmonary disease	18	28.57142857142857	1.1572470313703128E-12	TP53, IGF1, CHEK1, CDK4, PTEN, ATM, TP53I3, CCND1, CASP3, CDKN2A, CCND3, CASP9, BAX, CASP8, MDM2, APAF1, FAS, IGFBP3	58	414	12971	9.723388305847076	1.3332055459613912E-9	1.025542983867922E-10	1.8614554342377687E-9
GOTERM_BP_DIRECT	GO:0090399~replicative senescence	7	11.11111111111111	1.7947404298606142E-12	CDKN1A, CDKN2A, TP53, CHEK1, CHEK2, ATR, ATM	63	12	16792	155.48148148148147	1.4555718852449218E-9	2.425952772000528E-10	2.7599478258366617E-9
GAD_DISEASE	Leukemia, Lymphocytic, Chronic, B-Cell	14	22.22222222222222	5.342334281909054E-12	BID, CASP3, CCND1, TNFRSF10B, CASP9, BAX, CASP8, TP53, MDM2, CDK6, APAF1, ATR, TP73, ATM	58	212	12971	14.768542615484712	6.154309062367247E-9	4.395934727341455E-10	8.592815348151817E-9
KEGG_PATHWAY	hsa04068:FoxO signaling pathway	15	23.809523809523807	7.061210977523186E-12	IGF1, CCNG2, PTEN, CDK2, ATM, CCNB1, CCNB3, CDKN1A, CCND1, CCNB2, CCND2, GADD45G, MDM2, GADD45B, GADD45A	63	134	6910	12.277896233120114	7.484914910094176E-10	1.871228727523544E-10	7.923428579914571E-9
KEGG_PATHWAY	hsa05203:Viral carcinogenesis	17	26.984126984126984	1.648410793917396E-11	TP53, CHEK1, CDK6, PMAIP1, CDK4, CDK2, CCNE2, CCNE1, CDKN1A, CCND1, CASP3, CDKN2A, CCND3, CCND2, BAX, CASP8, MDM2	63	205	6910	9.095625241966705	1.7473196223249943E-9	3.4946390226053836E-10	1.8496892906227913E-8
GOTERM_BP_DIRECT	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	10	15.873015873015872	1.8502021986479237E-11	BID, CASP3, CDKN2A, TNFRSF10B, BBC3, BAX, CASP8, APAF1, FAS, PMAIP1	63	83	16792	32.11321476381717	1.5005103826126742E-8	2.1435863084562357E-9	2.845155222530593E-8
GOTERM_CC_DIRECT	GO:0005829~cytosol	35	55.55555555555556	9.552186690558219E-11	BID, CHEK1, PMAIP1, SFN, SESN2, SESN1, PTEN, GTSE1, CCNE2, CCNE1, CASP3, TP53I3, CDKN2A, CASP9, CASP8, FAS, CYCS, TP53, CDK6, CDK4, TP73, CDK2, RFWD2, CCNB1, CCND1, CDKN1A, CCNB2, CCND2, BBC3, RRM2, BAX, TSC2, MDM2, SIAH1, APAF1	63	3315	18224	3.0541310541310542	1.1653661036170604E-8	5.826830573596453E-9	1.0998064681189135E-7
KEGG_PATHWAY	hsa05162:Measles	14	22.22222222222222	1.0260771835253614E-10	TP53, CDK6, CDK4, TP73, CDK2, CCNE2, CCNE1, CCND1, TNFRSF10B, CCND3, CCND2, BBC3, RCHY1, FAS	63	133	6910	11.545530492898912	1.0876416101091024E-8	1.8127360723596553E-9	1.1513630049364565E-7
UP_KEYWORDS	Cell division	14	22.22222222222222	1.121222281386079E-10	CCNE2, CCNB1, CCNE1, CCNB3, CCND1, CCNB2, CCND3, CCND2, CDK6, CHEK2, CCNG1, CDK4, CCNG2, CDK2	63	388	20581	11.787514318442152	1.3454663938539113E-8	3.363666012390354E-9	1.2870868815184622E-7
KEGG_PATHWAY	hsa04210:Apoptosis	11	17.46031746031746	1.1891421289196709E-10	BID, CASP3, TNFRSF10B, CASP9, BAX, CYCS, CASP8, TP53, APAF1, FAS, ATM	63	62	6910	19.459805427547362	1.2604906340918376E-8	1.8007009217058112E-9	1.3343386395803236E-7
GOTERM_CC_DIRECT	GO:0005654~nucleoplasm	32	50.79365079365079	1.5183671303876747E-10	CHEK1, RRM2B, CHEK2, CCNG1, PTEN, GTSE1, CCNE2, CCNE1, CASP3, CDKN2A, CASP8, RCHY1, TP53, CDK6, ATR, CDK4, ATM, CDK2, TP73, RFWD2, CCNB1, CCNB3, CDKN1A, CCND1, CCNB2, CCND3, CCND2, RRM2, DDB2, MDM2, MDM4, GADD45A	63	2784	18224	3.324940704251049	1.8524085154680847E-8	6.1746950885677165E-9	1.7481980307820777E-7
GAD_DISEASE_CLASS	RENAL	26	41.269841269841265	2.2936949017489892E-10	BID, CHEK1, CHEK2, SESN1, CCNE1, CASP3, CDKN2A, CASP9, SERPINE1, FAS, THBS1, TP53, IGF1, CDK6, ATR, CDK4, ATM, CDK2, CDKN1A, CCND1, CCND3, CCND2, BAX, GADD45G, MDM2, IGFBP3	58	1417	12971	4.103448275862069	4.128651420742813E-9	2.0643257103714063E-9	1.6907356625850412E-7
GOTERM_BP_DIRECT	GO:0006974~cellular response to DNA damage stimulus	12	19.047619047619047	2.364649783072964E-10	CDKN1A, CCND1, CASP9, BBC3, ZMAT3, TP53, CHEK1, CHEK2, ATR, PMAIP1, ATM, TP73	63	208	16792	15.377289377289376	1.9177306320727894E-7	2.397163489931131E-8	3.6362576283366366E-7
UP_SEQ_FEATURE	mutagenesis site	27	42.857142857142854	3.505979351196901E-10	CHEK1, CHEK2, PMAIP1, PTEN, CCNE2, TP53I3, CASP8, RCHY1, THBS1, TP53, ATR, ATM, CDK2, TP73, RFWD2, PPM1D, CCNB3, CDKN1A, CCND1, BAX, RRM2, TSC2, DDB2, MDM2, SIAH1, MDM4, APAF1	63	2191	20063	3.9244311142987547	8.168930365481941E-8	8.168930365481941E-8	4.5041098628573195E-7
GOTERM_BP_DIRECT	GO:0051301~cell division	14	22.22222222222222	3.714836160764971E-10	CCNE2, CCNB1, CCNE1, CCNB3, CCND1, CCNB2, CCND3, CCND2, CDK6, CHEK2, CCNG1, CDK4, CCNG2, CDK2	63	350	16792	10.661587301587302	3.0127317185435487E-7	3.347480137527725E-8	5.712517237022041E-7
BIOCARTA	h_cellcyclePathway:Cyclins and Cell Cycle Regulation	10	15.873015873015872	4.0179350131747806E-10	CCNB1, CCNE1, CDKN1A, CCND1, CDKN2A, CCND3, CCND2, CDK6, CDK4, CDK2	35	25	1625	18.57142857142857	3.053630459604051E-8	1.5268152409042557E-8	4.228075334289372E-7
GOTERM_MF_DIRECT	GO:0019901~protein kinase binding	14	22.22222222222222	4.3308827529507525E-10	TP53, SFN, CHEK2, PTEN, TP73, CCNB1, CCNE2, CCNE1, CCND1, CCNB3, CDKN2A, CCND3, CASP9, CCND2	60	376	16881	10.475797872340426	7.016029113238176E-8	3.5080146232324694E-8	5.240583411669775E-7
GAD_DISEASE	Neoplasms	11	17.46031746031746	5.362686492618916E-10	CCND1, CDKN2A, CASP8, TP53, MDM2, CHEK2, ATR, FAS, MDM4, PTEN, ATM	58	143	12971	17.20291777188329	6.177813473007276E-7	4.1185435062374154E-8	8.625639202897162E-7
GOTERM_BP_DIRECT	GO:0097193~intrinsic apoptotic signaling pathway	7	11.11111111111111	1.0954132802747919E-9	CDKN1A, BBC3, BAX, CYCS, TP53, APAF1, PMAIP1	63	30	16792	62.19259259259259	8.883798048309188E-7	8.883801594361529E-8	1.6844800110327185E-6
GOTERM_BP_DIRECT	GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	7	11.11111111111111	1.0954132802747919E-9	BID, BBC3, CASP8, TP53, PMAIP1, SFN, TP73	63	30	16792	62.19259259259259	8.883798048309188E-7	8.883801594361529E-8	1.6844800110327185E-6
GOTERM_BP_DIRECT	GO:0007050~cell cycle arrest	10	15.873015873015872	2.231416395615223E-9	CDKN1A, CDKN2A, TSC2, TP53, RPRM, CDK6, THBS1, GADD45A, ATM, TP73	63	141	16792	18.90352358437465	1.8096770527664674E-6	1.6451623108260094E-7	3.431377193496843E-6
BIOCARTA	h_g1Pathway:Cell Cycle: G1/S Check Point 	10	15.873015873015872	2.621897391601279E-9	CCNE1, CDKN1A, CCND1, CDKN2A, TP53, CDK6, ATR, CDK4, ATM, CDK2	35	30	1625	15.476190476190474	1.9926418026727788E-7	6.642139782631062E-8	2.7590241535868643E-6
KEGG_PATHWAY	hsa05222:Small cell lung cancer	11	17.46031746031746	2.9524947623251978E-9	CCNE2, CCNE1, CCND1, CASP9, CYCS, TP53, CDK6, APAF1, CDK4, PTEN, CDK2	63	85	6910	14.194211017740429	3.1296440072825504E-7	3.912055546173576E-8	3.313000129789856E-6
GOTERM_BP_DIRECT	GO:0000082~G1/S transition of mitotic cell cycle	9	14.285714285714285	3.618274113599604E-9	CCNE2, CCNE1, CDKN1A, CCND1, CDKN2A, RRM2, CDK6, CDK4, CDK2	63	102	16792	23.518207282913163	2.9344160150657217E-6	2.445349968072108E-7	5.5640279716939745E-6
KEGG_PATHWAY	hsa05200:Pathways in cancer	19	30.158730158730158	4.815807910138076E-9	BID, CYCS, TP53, IGF1, CDK6, CDK4, PTEN, CDK2, CCNE2, CCNE1, CASP3, CDKN1A, CCND1, CDKN2A, CASP9, BAX, CASP8, MDM2, FAS	63	393	6910	5.302718203481562	5.10475504422736E-7	5.6719513419345446E-8	5.403827263439354E-6
GAD_DISEASE	Carcinoma|Prostatic Neoplasms	5	7.936507936507936	4.993131088333135E-9	CDKN1A, CCND1, CDKN2A, TP53, MDM2	58	6	12971	186.36494252873564	5.752070533771025E-6	3.59505377689473E-7	8.031225129379038E-6
GAD_DISEASE	Hodgkin Disease|Leukemia, Lymphocytic, Chronic, B-Cell|Lymphoproliferative Disorders|Waldenstrom Macroglobulinemia	10	15.873015873015872	5.660657144881738E-9	TP53I3, CASP3, CCND1, TNFRSF10B, CASP9, BAX, CASP8, TP53, MDM2, FAS	58	133	12971	16.814882032667878	6.521055810670973E-6	3.835926953854596E-7	9.104910458912485E-6
GOTERM_BP_DIRECT	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	7	11.11111111111111	5.8658730521779735E-9	CCNE2, CCNB3, CDKN1A, SFN, CCNG1, PTEN, GADD45A	63	39	16792	47.84045584045584	4.757211709116582E-6	3.6594016572522037E-7	9.020289748473687E-6
GOTERM_BP_DIRECT	GO:0043525~positive regulation of neuron apoptotic process	7	11.11111111111111	1.0836022164643666E-8	CASP3, CASP9, BBC3, BAX, TP53, PMAIP1, ATM	63	43	16792	43.39018087855297	8.787975429802586E-6	6.277150919054009E-7	1.6663172941466797E-5
GAD_DISEASE	Mouth Neoplasms|Precancerous Conditions	6	9.523809523809524	1.1234280406631421E-8	CDKN1A, CCND1, TP53, CDK6, CDK4, ATM	58	18	12971	74.54597701149424	1.2941807341682043E-5	7.189936908069683E-7	1.806983002117235E-5
BIOCARTA	h_g2Pathway:Cell Cycle: G2/M Checkpoint	9	14.285714285714285	1.296185410780053E-8	CCNB1, CDKN1A, TP53, MDM2, CHEK1, CHEK2, ATR, GADD45A, ATM	35	25	1625	16.71428571428571	9.851004362237958E-7	2.4627520001097025E-7	1.3639766149875499E-5
GAD_DISEASE	Colorectal Neoplasms	9	14.285714285714285	1.4384645720408907E-8	CDKN1A, CCND1, CDKN2A, TP53, CHEK2, FAS, GADD45A, ATM, TP73	58	103	12971	19.54117843990626	1.657097466178925E-5	8.721634071617856E-7	2.313704904333136E-5
GOTERM_BP_DIRECT	GO:0010165~response to X-ray	6	9.523809523809524	1.4604976962573446E-8	CDKN1A, CASP3, CCND1, TP53, PMAIP1, TP73	63	22	16792	72.6926406926407	1.1844566290553082E-5	7.896421174713453E-7	2.2458910364786533E-5
GOTERM_BP_DIRECT	GO:1901796~regulation of signal transduction by p53 class mediator	9	14.285714285714285	1.705331668870272E-8	TP53, MDM2, CHEK1, CHEK2, ATR, MDM4, ATM, CDK2, TP73	63	124	16792	19.345622119815665	1.3830144281912204E-5	8.643896213245128E-7	2.6223862115148933E-5
KEGG_PATHWAY	hsa05206:MicroRNAs in cancer	16	25.396825396825395	1.905589704962639E-8	TP53, CDK6, CCNG1, PTEN, ATM, CCNE2, CCNE1, CDKN1A, CCND1, CASP3, CDKN2A, CCND2, SERPINB5, MDM2, MDM4, THBS1	63	285	6910	6.15761626287942	2.0199230699180504E-6	2.019924906226933E-7	2.138265722262389E-5
GOTERM_BP_DIRECT	GO:0008635~activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	5	7.936507936507936	2.093300687394647E-8	CASP3, CASP9, BAX, CYCS, APAF1	63	9	16792	148.07760141093473	1.697652465737498E-5	9.986270754769322E-7	3.218988319231286E-5
GAD_DISEASE	Stomach Neoplasms	9	14.285714285714285	2.993186643568665E-8	CCND1, CDKN2A, SERPINE1, TP53, MDM2, CHEK2, FAS, IGFBP3, TP73	58	113	12971	17.811870613365883	3.448091616276017E-5	1.7240740459723014E-6	4.8144041575604035E-5
GAD_DISEASE	endometrial cancer	7	11.11111111111111	3.9215126695534287E-8	CCND1, TP53, MDM2, CHEK2, PTEN, ATM, TP73	58	45	12971	34.78812260536399	4.517480643362326E-5	2.1512275358848143E-6	6.307573777730724E-5
GOTERM_CC_DIRECT	GO:0005634~nucleus	40	63.49206349206349	6.215523168367905E-8	CHEK1, SFN, PMAIP1, SESN2, PTEN, SESN1, SESN3, CCNE2, CCNE1, CASP3, CDKN2A, CASP9, FAS, RCHY1, CYCS, TP53, CDK6, CDK4, TP73, ATM, CDK2, CCNB1, PPM1D, CCND1, CDKN1A, CCNB2, CCND3, CCND2, RRM2, BAX, TSC2, GADD45G, DDB2, MDM2, SIAH1, APAF1, MDM4, GADD45B, GADD45A, IGFBP3	63	5415	18224	2.1368039982998432	7.582909743897304E-6	1.8957328267177331E-6	7.156344529191117E-5
UP_KEYWORDS	Ubl conjugation	21	33.33333333333333	6.422216725746616E-8	BID, TP53, CHEK1, SFN, CHEK2, PTEN, TP73, CCNB1, RFWD2, CCNE1, CCNB3, CCND1, CDKN1A, CDKN2A, CCND3, CCND2, TSC2, DDB2, MDM2, RCHY1, MDM4	63	1705	20581	4.023655913978494	7.706630621329147E-6	1.5413308757095123E-6	7.372267192273796E-5
KEGG_PATHWAY	hsa05215:Prostate cancer	10	15.873015873015872	6.796981895241844E-8	CCNE2, CCNE1, CDKN1A, CCND1, CASP9, TP53, MDM2, IGF1, PTEN, CDK2	63	88	6910	12.463924963924963	7.204775103852867E-6	6.549816998768776E-7	7.626904003910084E-5
BIOCARTA	h_atmPathway:ATM Signaling Pathway	8	12.698412698412698	8.683979208456037E-8	CDKN1A, TP53, MDM2, CHEK1, CHEK2, GADD45A, ATM, TP73	35	21	1625	17.687074829931973	6.599802710005598E-6	1.3199640266359225E-6	9.138152823329193E-5
KEGG_PATHWAY	hsa05214:Glioma	9	14.285714285714285	8.925360757587669E-8	CDKN1A, CCND1, CDKN2A, TP53, MDM2, IGF1, CDK6, CDK4, PTEN	63	65	6910	15.186813186813186	9.460838075514566E-6	7.884065916785588E-7	1.0015160158971526E-4
GAD_DISEASE	Adenocarcinoma|Pancreatic Neoplasms	7	11.11111111111111	1.075849109386313E-7	CDKN1A, CDKN2A, MDM2, CHEK1, ATR, ATM, TP73	58	53	12971	29.537085230969424	1.2393014414102677E-4	5.633521591441593E-6	1.7304531961803704E-4
GAD_DISEASE	Occupational Diseases	5	7.936507936507936	1.0806516509554829E-7	CDKN1A, CDKN2A, TP53, MDM2, GADD45A	58	11	12971	101.65360501567399	1.2448332828651765E-4	5.412640872393126E-6	1.7381778546488036E-4
GOTERM_MF_DIRECT	GO:0004693~cyclin-dependent protein serine/threonine kinase activity	6	9.523809523809524	1.1292772261733848E-7	CCNB1, CCNB2, CCND3, CDK6, CDK4, CDK2	60	34	16881	49.650000000000006	1.829412475751191E-5	6.098078772276416E-6	1.366480851916485E-4
BIOCARTA	h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage	8	12.698412698412698	1.2549728872417295E-7	BID, CASP3, CASP9, BAX, CYCS, TP53, APAF1, ATM	35	22	1625	16.88311688311688	9.537749052990208E-6	1.5896311594820745E-6	1.3206079418903727E-4
GOTERM_BP_DIRECT	GO:2001244~positive regulation of intrinsic apoptotic signaling pathway	6	9.523809523809524	1.2759102558458533E-7	BID, BBC3, BAX, TP53, SIAH1, PMAIP1	63	33	16792	48.461760461760456	1.0347097489971091E-4	5.74866838687349E-6	1.9620387481378287E-4
GAD_DISEASE	head and neck cancer	8	12.698412698412698	1.3162237438880437E-7	CDKN1A, CCND1, CDKN2A, TNFRSF10B, TP53, CDK6, FAS, TP73	58	91	12971	19.660477453580903	1.516174902448375E-4	6.317854431392433E-6	2.1170842191553518E-4
KEGG_PATHWAY	hsa05218:Melanoma	9	14.285714285714285	1.804006882975214E-7	CDKN1A, CCND1, CDKN2A, TP53, MDM2, IGF1, CDK6, CDK4, PTEN	63	71	6910	13.903420523138832	1.912229184886094E-5	1.4709585091088329E-6	2.0242777771795062E-4
GAD_DISEASE	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	7	11.11111111111111	2.0691654198280357E-7	CASP3, CASP9, BAX, CASP8, TP53, APAF1, FAS	58	59	12971	26.533313851548805	2.383394736922284E-4	9.534669787036876E-6	3.3281537341611767E-4
GAD_DISEASE	Clubfoot	6	9.523809523809524	2.1330346852312042E-7	BID, CASP3, CASP9, CASP8, APAF1, IGFBP3	58	31	12971	43.28476084538376	2.456954339141726E-4	9.450940800403984E-6	3.4308842313812704E-4
GAD_DISEASE	prostate cancer	14	22.22222222222222	2.3081362137179322E-7	TP53, IGF1, CHEK2, PTEN, ATM, CDKN1A, CCND1, CASP9, SERPINE1, CASP8, MDM2, MDM4, THBS1, IGFBP3	58	510	12971	6.139080459770115	2.6586197489497643E-4	9.848000487977515E-6	3.712526170263075E-4
GAD_DISEASE	melanoma	8	12.698412698412698	2.3562263171938704E-7	CDKN1A, CDKN2A, TP53, IGF1, APAF1, FAS, CDK4, ATM	58	99	12971	18.071752002786486	2.7140046796980677E-4	9.694142430793917E-6	3.7898766540589435E-4
KEGG_PATHWAY	hsa04151:PI3K-Akt signaling pathway	16	25.396825396825395	2.4029789138021776E-7	TP53, IGF1, CDK6, CDK4, PTEN, CDK2, CCNE2, CCNE1, CDKN1A, CCND1, CCND3, CASP9, CCND2, TSC2, MDM2, THBS1	63	345	6910	5.086726478030825	2.547125514695825E-5	1.8193968838176033E-6	2.6963840167315567E-4
GAD_DISEASE	squamous cell carcinoma of the head and neck	4	6.349206349206349	3.2085379651647794E-7	CDKN1A, CCND1, CDKN2A, TP73	58	4	12971	223.63793103448276	3.6955533050264666E-4	1.2745561288496354E-5	5.160775610413282E-4
GAD_DISEASE	Carcinoma, Pancreatic Ductal|DNA Damage|Pancreatic Neoplasms	4	6.349206349206349	3.2085379651647794E-7	CHEK1, CHEK2, ATR, ATM	58	4	12971	223.63793103448276	3.6955533050264666E-4	1.2745561288496354E-5	5.160775610413282E-4
GAD_DISEASE	Melanoma|Skin Neoplasms	7	11.11111111111111	3.385393220879578E-7	CDKN2A, CASP8, TP53, MDM2, CHEK2, FAS, CDK4	58	64	12971	24.46039870689655	3.899213260226686E-4	1.2999827671889008E-5	5.445237870493891E-4
BIOCARTA	h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth	7	11.11111111111111	3.660276920465944E-7	CCNB1, CCNB2, TP53, CDK6, SFN, CDK4, CDK2	35	16	1625	20.3125	2.7817722766498854E-5	3.974007773077659E-6	3.8517049137931636E-4
GAD_DISEASE_CLASS	OTHER	23	36.507936507936506	3.909665512837641E-7	TP53, IGF1, CHEK1, CDK4, PTEN, ATM, RFWD2, TP53I3, CASP3, CDKN1A, CCND1, CDKN2A, CCND3, CASP9, BAX, GADD45G, CASP8, SERPINE1, TSC2, MDM2, FAS, APAF1, IGFBP3	58	1595	12971	3.22487298670414	7.037374535667773E-6	2.3457970146356644E-6	2.8819010555736213E-4
GOTERM_BP_DIRECT	GO:0034349~glial cell apoptotic process	4	6.349206349206349	4.7681610598256935E-7	BID, CASP3, CASP9, APAF1	63	5	16792	213.231746031746	3.8662319608551154E-4	2.0352316788985192E-5	7.332250228975212E-4
BBID	94.E2F_transcriptional_activity_cell_cycle	6	9.523809523809524	5.659141635179962E-7	CDKN1A, CDKN2A, TP53, CDK6, CDK4, CDK2	15	7	388	22.171428571428574	1.4713664168164442E-5	1.4713664168164442E-5	4.640927259158545E-4
GAD_DISEASE	lymphoma	7	11.11111111111111	5.801680263938834E-7	CDKN1A, CDKN2A, TP53, MDM2, FAS, ATM, CDK2	58	70	12971	22.363793103448277	6.681304616654726E-4	2.1559566308226863E-5	9.331699287962181E-4
GOTERM_BP_DIRECT	GO:0071157~negative regulation of cell cycle arrest	5	7.936507936507936	7.808033091136659E-7	CCND1, MDM2, CHEK2, MDM4, CDK4	63	20	16792	66.63492063492063	6.330312820105322E-4	3.1661085322820526E-5	0.0012006793939867144
GOTERM_BP_DIRECT	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	6	9.523809523809524	7.926009607770834E-7	CASP9, BAX, CHEK2, SFN, ATM, TP73	63	47	16792	34.02634245187436	6.425930824871529E-4	3.060903791063385E-5	0.001218821115900326
GAD_DISEASE	Leukemia, Myelogenous, Chronic, BCR-ABL Positive|Neovascularization, Pathologic	6	9.523809523809524	8.015579509700038E-7	CASP3, CASP9, BAX, CASP8, APAF1, FAS	58	40	12971	33.54568965517241	9.229689315553014E-4	2.8855681468265004E-5	0.0012892618914905896
UP_KEYWORDS	Tumor suppressor	8	12.698412698412698	1.0200859747494826E-6	CDKN2A, BAX, TSC2, TP53, CHEK2, PTEN, ATM, TP73	63	177	20581	14.76531252802439	1.224028875659311E-4	2.0401521787949406E-5	0.0011709833258710667
UP_KEYWORDS	DNA damage	10	15.873015873015872	1.0325757381342456E-6	CCND1, ZMAT3, DDB2, CHEK1, CHEK2, ATR, RRM2B, GADD45A, ATM, CDK2	63	352	20581	9.280753968253968	1.2390147612706404E-4	1.77011508397662E-5	0.0011853205737488715
UP_KEYWORDS	Cytoplasm	33	52.38095238095239	1.305942001282594E-6	BID, RPRM, CHEK1, SFN, RRM2B, SESN2, CCNG2, SESN1, PTEN, GTSE1, SESN3, CASP3, CDKN2A, CASP8, RCHY1, TP53, CDK6, CDK4, TP73, CDK2, RFWD2, CCNB1, CCND1, CDKN1A, EI24, CCND3, CCND2, RRM2, BAX, TSC2, MDM2, SIAH1, APAF1	63	4816	20581	2.238480857459263	1.5670086362418179E-4	1.9588950944893213E-5	0.0014991226773064525
GOTERM_BP_DIRECT	GO:0001836~release of cytochrome c from mitochondria	5	7.936507936507936	1.415254424686094E-6	BID, BBC3, BAX, PMAIP1, SFN	63	23	16792	57.943409247757074	0.0011471137120699915	5.217010048330639E-5	0.002176295944023021
GOTERM_BP_DIRECT	GO:0071456~cellular response to hypoxia	7	11.11111111111111	1.415855558884669E-6	CCNB1, BBC3, TP53, MDM2, MDM4, PMAIP1, PTEN	63	96	16792	19.435185185185183	0.0011476006732794586	4.9923087329761806E-5	0.00217722032390677
KEGG_PATHWAY	hsa05219:Bladder cancer	7	11.11111111111111	1.4353474408845849E-6	CDKN1A, CCND1, CDKN2A, TP53, MDM2, THBS1, CDK4	63	41	6910	18.726287262872628	1.52135364169248E-4	1.0143077753821395E-5	0.001610594349998884
GAD_DISEASE	Neoplasm Recurrence, Local|Prostatic Neoplasms	4	6.349206349206349	1.5942663412462114E-6	CDKN1A, TP53, MDM2, PTEN	58	6	12971	149.0919540229885	0.0018349107782231755	5.565288432574089E-5	0.002564274419747381
GOTERM_BP_DIRECT	GO:0042493~response to drug	10	15.873015873015872	1.6227054269362716E-6	CCNB1, CDKN1A, CASP3, CCND1, MDM2, ATR, THBS1, CDK4, PTEN, TP73	63	304	16792	8.767752715121135	0.0013151496007627328	5.4832462019871464E-5	0.002495298308813343
GAD_DISEASE	benzene haematotoxicity	10	15.873015873015872	1.88143278668525E-6	TP53I3, CASP3, CCND1, TNFRSF10B, CASP9, BAX, CASP8, TP53, MDM2, FAS	58	262	12971	8.535798894445907	0.0021650654665120728	6.374539785736211E-5	0.003026156541818814
GAD_DISEASE	Head and Neck Neoplasms|Neoplasm Recurrence, Local|Neoplasms, Second Primary	8	12.698412698412698	2.358395268829997E-6	CDKN2A, BAX, CASP8, DDB2, FAS, MDM4, RRM2B, CDK4	58	139	12971	12.871247829322748	0.0027131871899066518	7.762197450011943E-5	0.0037933045749283245
GAD_DISEASE	multiple myeloma	8	12.698412698412698	2.7198852186321436E-6	CASP3, TNFRSF10B, CASP9, CASP8, TP53, IGF1, FAS, IGFBP3	58	142	12971	12.59932005828072	0.0031284083337550506	8.703265779841374E-5	0.0043747225283330415
GOTERM_BP_DIRECT	GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator	5	7.936507936507936	2.774097184306783E-6	ZMAT3, BAX, TP53, PMAIP1, PERP	63	27	16792	49.359200470311585	0.002247267043019363	8.998778833779753E-5	0.004265803640191024
BIOCARTA	h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling	7	11.11111111111111	3.117311398515789E-6	BID, CASP3, CASP9, BAX, CYCS, CASP8, APAF1	35	22	1625	14.772727272727273	2.3688797317433785E-4	2.9614065940153367E-5	0.0032802999882064476
GOTERM_BP_DIRECT	GO:0090200~positive regulation of release of cytochrome c from mitochondria	5	7.936507936507936	3.2275153321640073E-6	BID, BBC3, BAX, TP53, PMAIP1	63	28	16792	47.59637188208617	0.0026140964421915713	1.0066874634895306E-4	0.004963020709647381
GAD_DISEASE	Glioma	5	7.936507936507936	3.3347866625392893E-6	CDKN2A, CASP8, TP53, CDK4, PTEN	58	24	12971	46.59123563218391	0.0038343108263383385	1.0382381644524763E-4	0.005363718506068427
GOTERM_MF_DIRECT	GO:0002039~p53 binding	6	9.523809523809524	3.5892783635840843E-6	CDKN2A, ZMAT3, TP53, MDM2, RCHY1, TP73	60	67	16881	25.1955223880597	5.812951209166473E-4	1.4535546947691547E-4	0.004343119129446293
GAD_DISEASE	Brain Neoplasms|Glioblastoma	5	7.936507936507936	3.9570220584577406E-6	CDKN2A, TP53, MDM2, CDK4, PTEN	58	25	12971	44.727586206896554	0.004548124245981278	1.1995329003922084E-4	0.0063645009366175564
GOTERM_BP_DIRECT	GO:1904262~negative regulation of TORC1 signaling	4	6.349206349206349	3.963214943280986E-6	SESN2, SESN1, ATM, SESN3	63	9	16792	118.4620811287478	0.0032090137617222236	1.1903638454024978E-4	0.006094289813807219
KEGG_PATHWAY	hsa05014:Amyotrophic lateral sclerosis (ALS)	7	11.11111111111111	4.764226501521674E-6	BID, CASP3, CASP9, BAX, CYCS, TP53, APAF1	63	50	6910	15.355555555555556	5.048817164632347E-4	3.156257765091208E-5	0.005345817694835109
GAD_DISEASE	Esophageal Cancer	6	9.523809523809524	4.81876252880362E-6	CDKN1A, CCND1, TP53, MDM2, FAS, TP73	58	57	12971	23.54083484573503	0.0055358482148024635	1.4232904482924802E-4	0.007750479740609162
GOTERM_BP_DIRECT	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	5	7.936507936507936	4.918947530487717E-6	CDKN1A, TP53, CHEK2, PMAIP1, TP73	63	31	16792	42.990271377368146	0.003981329666806976	1.4246400313921992E-4	0.007563880914740473
GOTERM_BP_DIRECT	GO:0046677~response to antibiotic	5	7.936507936507936	5.606144893084394E-6	CASP3, CASP9, CASP8, TP53, MDM2	63	32	16792	41.6468253968254	0.004536276130403527	1.567668919155718E-4	0.008620543850024198
GOTERM_BP_DIRECT	GO:0097190~apoptotic signaling pathway	6	9.523809523809524	6.285937409466675E-6	CASP3, BBC3, BAX, CASP8, APAF1, FAS	63	71	16792	22.52448021462106	0.005084938965296715	1.6991593804083216E-4	0.009665810517256457
GOTERM_BP_DIRECT	GO:0051402~neuron apoptotic process	5	7.936507936507936	6.361807495555761E-6	BID, BAX, SIAH1, APAF1, ATM	63	33	16792	40.38480038480038	0.0051461552293444734	1.6641977297116028E-4	0.00978246970270158
GOTERM_BP_DIRECT	GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	5	7.936507936507936	6.361807495555761E-6	TNFRSF10B, BBC3, BAX, APAF1, PMAIP1	63	33	16792	40.38480038480038	0.0051461552293444734	1.6641977297116028E-4	0.00978246970270158
UP_KEYWORDS	Alternative splicing	50	79.36507936507937	6.566535636362821E-6	STEAP3, ZMAT3, PMAIP1, PTEN, CCNE2, CCNE1, TP53I3, CDKN2A, CASP9, SERPINE1, CASP8, FAS, TP53, CDK4, CDK2, RFWD2, PPM1D, TNFRSF10B, CCND3, CCND2, SERPINB5, RRM2, CD82, DDB2, MDM2, SIAH1, MDM4, GADD45A, BID, CHEK1, SFN, CHEK2, RRM2B, CCNG1, CCNG2, SESN1, SESN3, RCHY1, THBS1, IGF1, ATR, TP73, CCNB1, CCNB3, EI24, BBC3, BAX, TSC2, APAF1, IGFBP3	63	10587	20581	1.5428475473814094	7.87676483419153E-4	8.755026320061976E-5	0.007537678656677205
GAD_DISEASE	Adenocarcinoma|Lymphatic Metastasis|Stomach Neoplasms	4	6.349206349206349	6.633415639523872E-6	BID, CASP3, CASP9, TP53	58	9	12971	99.39463601532567	0.007612596450933262	1.910247565011236E-4	0.010669015037056973
GOTERM_BP_DIRECT	GO:0031571~mitotic G1 DNA damage checkpoint	4	6.349206349206349	7.74393834111434E-6	CCND1, TP53, CDK2, TP73	63	11	16792	96.92352092352093	0.006260678082962379	1.9624193928247102E-4	0.011907636246288877
GOTERM_BP_DIRECT	GO:0042770~signal transduction in response to DNA damage	4	6.349206349206349	7.74393834111434E-6	BID, CASP9, CHEK2, GADD45A	63	11	16792	96.92352092352093	0.006260678082962379	1.9624193928247102E-4	0.011907636246288877
BIOCARTA	h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system	7	11.11111111111111	9.059083909498325E-6	CDKN1A, BAX, TP53, MDM2, IGFBP3, GADD45A, ATM	35	26	1625	12.5	6.882565384219719E-4	7.64963513031347E-5	0.009532468311923559
GAD_DISEASE	Hepatitis C, Chronic|HIV Infections|Liver Diseases	4	6.349206349206349	9.446739095558041E-6	BID, TNFRSF10B, CASP8, FAS	58	10	12971	89.45517241379311	0.010823692546241492	2.6539635764510905E-4	0.01519356970811625
UP_KEYWORDS	Phosphoprotein	43	68.25396825396825	9.492632133214026E-6	STEAP3, BID, RPRM, CHEK1, CHEK2, SFN, SESN2, PTEN, SESN1, GTSE1, CCNE2, CCNE1, CASP3, CDKN2A, CASP9, CASP8, FAS, RCHY1, CYCS, TP53, CDK6, ATR, CDK4, TP73, ATM, CDK2, CCNB1, PPM1D, CCND1, CDKN1A, EI24, CCNB2, CCND3, CCND2, BBC3, RRM2, TSC2, DDB2, MDM2, SIAH1, MDM4, GADD45A, IGFBP3	63	8246	20581	1.7035349510488973	0.0011384727102839998	1.1390563852275992E-4	0.01089635655431298
GOTERM_BP_DIRECT	GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator	4	6.349206349206349	1.0298065426364232E-5	CDKN2A, ATR, PMAIP1, ATM	63	12	16792	88.84656084656085	0.00831699488938853	2.5305203948922106E-4	0.01583475490813946
BIOCARTA	h_plk3Pathway:Regulation of cell cycle progression by Plk3	5	7.936507936507936	1.0565400123455588E-5	TP53, CHEK1, CHEK2, ATR, ATM	35	8	1625	29.01785714285714	8.026523533902763E-4	8.029424137123709E-5	0.011117417670347685
GOTERM_BP_DIRECT	GO:0050821~protein stabilization	7	11.11111111111111	1.0704517910715822E-5	CDKN1A, CDKN2A, IGF1, CHEK2, MDM4, PTEN, GTSE1	63	136	16792	13.71895424836601	0.008643835859015514	2.5530300731146927E-4	0.01645968589686353
GOTERM_BP_DIRECT	GO:0000086~G2/M transition of mitotic cell cycle	7	11.11111111111111	1.1162833058092863E-5	CCNB1, PPM1D, CDKN1A, CCNB2, CHEK1, CHEK2, CDK2	63	137	16792	13.61881589618816	0.009012252140131904	2.586267828805777E-4	0.01716435266281291
GAD_DISEASE	Lymphoma, Non-Hodgkin	9	14.285714285714285	1.2084072391875607E-5	CASP3, CCND1, CDKN2A, CASP9, BAX, CASP8, IGF1, CDK4, IGFBP3	58	249	12971	8.08329871208974	0.01382448735189945	3.313959216264539E-4	0.01943491213362014
GAD_DISEASE	leukemia	7	11.11111111111111	1.2399447917985028E-5	CDKN1A, CCND1, CDKN2A, BAX, TP53, MDM2, ATM	58	118	12971	13.266656925774402	0.014182716654289274	3.3213675037591095E-4	0.019942085728963388
GAD_DISEASE	Carcinoma, Hepatocellular|LCC - Liver cell carcinoma|Liver neoplasms	5	7.936507936507936	1.246967265430621E-5	CCND1, TP53, MDM2, IGF1, IGFBP3	58	33	12971	33.88453500522466	0.0142624659502405	3.2642744874422647E-4	0.02005501785427022
GOTERM_BP_DIRECT	GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	4	6.349206349206349	1.335224127780476E-5	TNFRSF10B, BAX, CASP8, FAS	63	13	16792	82.01221001221	0.010770320226689445	3.0075309723043286E-4	0.020530538250929098
KEGG_PATHWAY	hsa05166:HTLV-I infection	12	19.047619047619047	1.3822735518194953E-5	CDKN1A, CCND1, CDKN2A, CCND3, CCND2, BAX, TP53, CHEK1, CHEK2, ATR, CDK4, ATM	63	256	6910	5.1413690476190474	0.0014641471807496087	8.61857029534896E-5	0.015509422862591826
GOTERM_BP_DIRECT	GO:0008285~negative regulation of cell proliferation	10	15.873015873015872	1.3841677490310296E-5	PPM1D, CDKN1A, CDKN2A, TSC2, TP53, CDK6, MDM4, IGFBP3, PTEN, TP73	63	396	16792	6.730800064133397	0.011162905319826444	3.0335068624975925E-4	0.021283025330331995
GOTERM_BP_DIRECT	GO:0032461~positive regulation of protein oligomerization	4	6.349206349206349	1.6949029811902733E-5	BID, BAX, TP53, PMAIP1	63	14	16792	76.15419501133786	0.013651737823190624	3.616656270709617E-4	0.02606032205431097
GOTERM_MF_DIRECT	GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity	4	6.349206349206349	1.7909055493791156E-5	CCNE2, CCNE1, CCND1, CDK4	60	15	16881	75.02666666666667	0.0028970882866578007	5.800902764963034E-4	0.0216686954962797
UP_SEQ_FEATURE	short sequence motif:BH3	4	6.349206349206349	1.852855666407185E-5	BID, BBC3, BAX, PMAIP1	63	17	20063	74.93183940242764	0.004307888014116634	0.0021562687545292336	0.02380091291162012
GOTERM_BP_DIRECT	GO:0034644~cellular response to UV	5	7.936507936507936	2.0473698350698005E-5	CASP9, BAX, TP53, ATR, TP73	63	44	16792	30.28860028860029	0.01646724712064007	4.256616711004746E-4	0.031478949534191614
GOTERM_BP_DIRECT	GO:0032355~response to estradiol	6	9.523809523809524	2.1218019981271706E-5	BID, CASP3, CCND1, CASP9, CASP8, PTEN	63	91	16792	17.57404500261643	0.0170607848060238	4.301073964138036E-4	0.03262319269392577
GOTERM_BP_DIRECT	GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	4	6.349206349206349	2.593836382822006E-5	CDKN1A, TP53, CHEK2, TP73	63	16	16792	66.63492063492063	0.020816566616852272	5.129485405334089E-4	0.03987947647496881
UP_KEYWORDS	Li-Fraumeni syndrome	3	4.761904761904762	2.673535553833268E-5	CDKN2A, TP53, CHEK2	63	3	20581	326.6825396825397	0.0032031445034786943	2.916197935992626E-4	0.03068607787025668
UP_KEYWORDS	Nucleus	32	50.79365079365079	2.8618698787387678E-5	ZMAT3, CHEK1, SFN, RRM2B, CHEK2, CCNG1, SESN1, PTEN, CCNE2, CCNE1, CDKN2A, RCHY1, TP53, CDK6, ATR, CDK4, TP73, ATM, CDK2, CCNB1, RFWD2, CCNB3, CCND1, CDKN1A, EI24, CCND3, CCND2, DDB2, MDM2, SIAH1, MDM4, GADD45A	63	5244	20581	1.9934861307859018	0.0034284025581123867	2.8615013433963554E-4	0.03284740135479636
INTERPRO	IPR024824:Growth arrest and DNA damage-inducible protein GADD45	3	4.761904761904762	3.077038314861587E-5	GADD45G, GADD45B, GADD45A	61	3	18559	304.24590163934425	0.004727501929904676	0.0011839765238823574	0.036905935444475624
INTERPRO	IPR015451:Cyclin D	3	4.761904761904762	3.077038314861587E-5	CCND1, CCND3, CCND2	61	3	18559	304.24590163934425	0.004727501929904676	0.0011839765238823574	0.036905935444475624
INTERPRO	IPR006730:PA26 p53-induced protein (sestrin)	3	4.761904761904762	3.077038314861587E-5	SESN2, SESN1, SESN3	61	3	18559	304.24590163934425	0.004727501929904676	0.0011839765238823574	0.036905935444475624
GAD_DISEASE_CLASS	UNKNOWN	20	31.746031746031743	3.3334846250686134E-5	CYCS, TP53, IGF1, CHEK2, ATM, CASP3, CDKN1A, CCND1, CDKN2A, CCND3, BAX, CASP8, SERPINE1, TSC2, MDM2, FAS, APAF1, THBS1, IGFBP3, GADD45A	58	1613	12971	2.772943968189495	5.998572473026043E-4	1.4999805757687223E-4	0.024569275021768533
BIOCARTA	h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors 	7	11.11111111111111	3.923435710850339E-5	BID, CASP3, TNFRSF10B, CASP9, CYCS, CASP8, APAF1	35	33	1625	9.84848484848485	0.0029774282788469497	2.710423192554545E-4	0.04127862579019759
KEGG_PATHWAY	hsa05220:Chronic myeloid leukemia	7	11.11111111111111	4.018606668700749E-5	CDKN1A, CCND1, CDKN2A, TP53, MDM2, CDK6, CDK4	63	72	6910	10.66358024691358	0.00425074854630525	2.3662803593971216E-4	0.0450836042111713
GOTERM_CC_DIRECT	GO:0005737~cytoplasm	34	53.96825396825397	4.073376098802008E-5	STEAP3, BID, RPRM, SFN, RRM2B, SESN2, CCNG2, SESN1, PTEN, SESN3, CASP3, CDKN2A, CASP8, FAS, RCHY1, TP53, CDK6, TP73, ATM, CDK2, RFWD2, CCNB1, CCND1, EI24, CCND3, SERPINB5, RRM2, BAX, GADD45G, TSC2, MDM2, SIAH1, GADD45B, GADD45A	63	5222	18224	1.8834114521590584	0.004957291925624774	9.934302325126376E-4	0.0468894577560941
GOTERM_BP_DIRECT	GO:0043066~negative regulation of apoptotic process	10	15.873015873015872	4.126965937257228E-5	CDKN1A, CASP3, CCND2, TP53, MDM2, IGF1, FAS, MDM4, THBS1, PTEN	63	455	16792	5.858015000872143	0.03291644844427277	7.965964630006761E-4	0.0634439030499534
GOTERM_MF_DIRECT	GO:0030332~cyclin binding	4	6.349206349206349	4.43164428617715E-5	CDKN1A, CDK6, CDK4, CDK2	60	20	16881	56.269999999999996	0.007153712337566787	0.0011958548663421054	0.05361191581736424
GOTERM_BP_DIRECT	GO:0046827~positive regulation of protein export from nucleus	4	6.349206349206349	4.452932227868852E-5	TP53, MDM2, SFN, GTSE1	63	19	16792	56.11361737677527	0.03546975068907243	8.395098431455139E-4	0.06845338326522121
GOTERM_BP_DIRECT	GO:0048146~positive regulation of fibroblast proliferation	5	7.936507936507936	4.639824563194485E-5	CCNB1, CDKN1A, IGF1, CDK6, CDK4	63	54	16792	24.679600235155792	0.03693064514103783	8.548582683379768E-4	0.07132545612927865
GOTERM_MF_DIRECT	GO:0042802~identical protein binding	12	19.047619047619047	4.858601403146963E-5	BAX, CASP8, TP53, MDM2, SIAH1, APAF1, CHEK2, FAS, SFN, THBS1, PTEN, TP73	60	749	16881	4.507610146862484	0.00784022929547401	0.0011238145452030501	0.05877564632695842
GOTERM_BP_DIRECT	GO:0071480~cellular response to gamma radiation	4	6.349206349206349	6.079761422350203E-5	CDKN1A, CHEK2, ATR, ATM	63	21	16792	50.7694633408919	0.048112443480087475	0.001095141318259718	0.09345113574721342
GAD_DISEASE	stomach cancer	6	9.523809523809524	6.175408772396304E-5	CDKN1A, CCND1, CDKN2A, TP53, MDM2, FAS	58	96	12971	13.977370689655173	0.06867120963423912	0.0015797044127963122	0.09928240460190807
BBID	26.cyclin-CDK_complexes	6	9.523809523809524	6.898261637761832E-5	CDKN1A, CDKN2A, CDK6, CCNG1, CDK4, CDK2	15	15	388	10.346666666666668	0.0017920023335161739	8.964029358697889E-4	0.05655706760745449
GOTERM_BP_DIRECT	GO:1901031~regulation of response to reactive oxygen species	3	4.761904761904762	8.009811238214357E-5	SESN2, SESN1, SESN3	63	4	16792	199.9047619047619	0.06289708748676093	0.001411224390465593	0.12310057407436403
GAD_DISEASE_CLASS	PHARMACOGENOMIC	26	41.269841269841265	8.068053247237002E-5	BID, RRM2B, PTEN, GTSE1, TP53I3, CASP3, CASP9, CASP8, SERPINE1, FAS, THBS1, TP53, IGF1, CDK6, CDK4, ATM, TP73, CDKN1A, CCND1, TNFRSF10B, BAX, MDM2, MDM4, APAF1, PERP, IGFBP3	58	2717	12971	2.1400758950668206	0.0014512540826245868	2.904194544611771E-4	0.05945619879601516
GAD_DISEASE	pancreatic neoplasm|Pancreatic Neoplasms	4	6.349206349206349	8.698496352057202E-5	CDKN2A, CASP9, TP53, CHEK2	58	20	12971	44.727586206896554	0.09535351550695426	0.002176129582084574	0.13981962349993715
GAD_DISEASE	overall effect	4	6.349206349206349	8.698496352057202E-5	CDKN1A, CDKN2A, CHEK2, IGFBP3	58	20	12971	44.727586206896554	0.09535351550695426	0.002176129582084574	0.13981962349993715
GAD_DISEASE	longevity	10	15.873015873015872	8.906010112840076E-5	TNFRSF10B, CASP9, TSC2, CASP8, SERPINE1, TP53, FAS, PERP, SESN1, GTSE1	58	425	12971	5.2620689655172415	0.0975137329277671	0.0021806360878657838	0.14315295935037886
BIOCARTA	h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage	5	7.936507936507936	1.0016762368934459E-4	TP53, CHEK1, CDK4, ATM, CDK2	35	13	1625	17.857142857142854	0.0075842142999476	6.342255189895063E-4	0.10535619211443636
BIOCARTA	h_d4gdiPathway:D4-GDI Signaling Pathway	5	7.936507936507936	1.0016762368934459E-4	CASP3, CASP9, CYCS, CASP8, APAF1	35	13	1625	17.857142857142854	0.0075842142999476	6.342255189895063E-4	0.10535619211443636
GAD_DISEASE	Lymphoma, B-Cell|Lymphoma, Follicular|Lymphoma, Large B-Cell, Diffuse	4	6.349206349206349	1.0116632236253955E-4	TP53I3, CCND1, BAX, TP53	58	21	12971	42.59770114942528	0.11001395744658293	0.0024251690747979504	0.1625973493149413
GAD_DISEASE	Abortion, Spontaneous	6	9.523809523809524	1.1302219525936621E-4	STEAP3, RRM2, TP53, MDM2, IGF1, IGFBP3	58	109	12971	12.310344827586206	0.12208800804709108	0.002653797484599818	0.181636201128188
GAD_DISEASE	Adenocarcinoma|Carcinoma, Pancreatic Ductal|Pancreatic Neoplasms	3	4.761904761904762	1.1319881033068788E-4	CDKN2A, MDM2, TP73	58	4	12971	167.72844827586206	0.12226663054667464	0.002604849694091582	0.1819197941641093
GOTERM_CC_DIRECT	GO:0005739~mitochondrion	15	23.809523809523807	1.2017201361908614E-4	BID, CYCS, TP53, SFN, RRM2B, PMAIP1, SESN2, PTEN, TP73, CDKN2A, CASP9, BBC3, BAX, CASP8, PERP	63	1331	18224	3.259990698007227	0.014554904876519892	0.00244066117346442	0.13827469055031072
GAD_DISEASE	Lymphoma, Non-Hodgkin|Lymphoma, Non-Hodgkin's	6	9.523809523809524	1.2316490652150786E-4	BID, CASP3, CASP9, BAX, CASP8, MDM2	58	111	12971	12.088536812674743	0.13228738748439128	0.002778382361377174	0.19792125558371065
GAD_DISEASE	Endometrial Neoplasms	5	7.936507936507936	1.2740439521973055E-4	TP53, MDM2, IGF1, IGFBP3, PTEN	58	59	12971	18.952367036820576	0.13651539801470125	0.0028186971779727843	0.20472740562195169
GOTERM_BP_DIRECT	GO:0007265~Ras protein signal transduction	5	7.936507936507936	1.287161907975533E-4	CDKN1A, CDKN2A, TP53, IGF1, CDK2	63	70	16792	19.03854875283447	0.09913111137309683	0.002218716906829954	0.1977512397754455
KEGG_PATHWAY	hsa05223:Non-small cell lung cancer	6	9.523809523809524	1.3269354390755262E-4	CCND1, CDKN2A, CASP9, TP53, CDK6, CDK4	63	56	6910	11.751700680272108	0.013967978695045624	7.400654341973567E-4	0.1487947548451496
GAD_DISEASE	Breast Neoplasms	4	6.349206349206349	1.3387314706704562E-4	CCND1, CCND3, IGF1, ATM	58	23	12971	38.8935532233883	0.14292700538011038	0.002905811243926526	0.21511161528090517
GOTERM_BP_DIRECT	GO:0071260~cellular response to mechanical stimulus	5	7.936507936507936	1.360254596529502E-4	TNFRSF10B, CASP8, CHEK1, FAS, GADD45A	63	71	16792	18.770400178850885	0.10445620352904672	0.002295780476395226	0.20896975018294128
KEGG_PATHWAY	hsa05416:Viral myocarditis	6	9.523809523809524	1.4445622140146745E-4	BID, CASP3, CCND1, CASP9, CYCS, CASP8	63	57	6910	11.545530492898912	0.015196810666836091	7.653802249084629E-4	0.16197499551497962
GOTERM_BP_DIRECT	GO:0007049~cell cycle	7	11.11111111111111	1.4616227635611754E-4	STEAP3, CCND1, CCND3, CCND2, TP53, SIAH1, ATR	63	217	16792	8.59805427547363	0.11178928265483756	0.0024163874534882668	0.22452612423260465
GAD_DISEASE	null	14	22.22222222222222	1.6417083107362327E-4	CCND1, CDKN1A, TNFRSF10B, CDKN2A, CCND3, BAX, SERPINE1, TP53, IGF1, MDM2, FAS, CHEK2, IGFBP3, TP73	58	936	12971	3.3450117889773066	0.17232964304224074	0.0034964716401104656	0.2637346369150251
BIOCARTA	h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition	6	9.523809523809524	1.7192543907998498E-4	CCNE1, CDKN1A, CCND1, CDK6, CDK4, CDK2	35	27	1625	10.317460317460318	0.012982448188488038	0.0010046839449745493	0.18076921318568306
GAD_DISEASE	Breast Neoplasms|	4	6.349206349206349	1.7278027457100602E-4	TP53, MDM2, IGF1, ATM	58	25	12971	35.78206896551724	0.18049933852383737	0.003612732388005635	0.27754738610999974
GAD_DISEASE	pancreatic cancer	5	7.936507936507936	1.7498568900946356E-4	CDKN1A, CDKN2A, TP53, CDK4, ATM	58	64	12971	17.471713362068968	0.18257911112487735	0.00359354828273184	0.28108540240150415
BIOCARTA	h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF	8	12.698412698412698	1.7983219878003518E-4	BID, CASP3, CASP9, CYCS, CASP8, MDM2, APAF1, FAS	35	61	1625	6.0889929742388755	0.01357548669680908	9.758432806907802E-4	0.18907557605357672
GOTERM_BP_DIRECT	GO:2000379~positive regulation of reactive oxygen species metabolic process	4	6.349206349206349	1.812487561128968E-4	CDKN1A, TP53, THBS1, GADD45A	63	30	16792	35.53862433862434	0.13671125753342683	0.002935803355072708	0.2783537685487669
GOTERM_BP_DIRECT	GO:0000077~DNA damage checkpoint	4	6.349206349206349	1.812487561128968E-4	CHEK1, CHEK2, ATR, ATM	63	30	16792	35.53862433862434	0.13671125753342683	0.002935803355072708	0.2783537685487669
GAD_DISEASE	fertility	3	4.761904761904762	1.8813159739242946E-4	TP53, MDM2, MDM4	58	5	12971	134.18275862068964	0.19486715425458478	0.0037953755914610365	0.30217216572396843
GAD_DISEASE	melanoma, sporadic primary	3	4.761904761904762	1.8813159739242946E-4	CDKN2A, TP53, CDK4	58	5	12971	134.18275862068964	0.19486715425458478	0.0037953755914610365	0.30217216572396843
GOTERM_BP_DIRECT	GO:0032025~response to cobalt ion	3	4.761904761904762	1.9929290513934786E-4	CASP3, CASP9, CASP8	63	6	16792	133.26984126984127	0.1492548391534323	0.003164446350321093	0.30602548334007773
GOTERM_BP_DIRECT	GO:0010332~response to gamma radiation	4	6.349206349206349	2.0014123561213677E-4	BAX, TP53, CHEK2, TP73	63	31	16792	34.392217101894516	0.14984006397272287	0.003116878324711858	0.3073262689959666
KEGG_PATHWAY	hsa05210:Colorectal cancer	6	9.523809523809524	2.1571125893470478E-4	CASP3, CCND1, CASP9, BAX, CYCS, TP53	63	62	6910	10.614439324116743	0.022608372193786197	0.0010883530263045005	0.24178336680589219
GAD_DISEASE	Leiomyoma|Uterine Neoplasms	4	6.349206349206349	2.183657043350588E-4	CDKN1A, CCND1, TP53, IGF1	58	27	12971	33.13154533844189	0.2224324526918393	0.004328274200052662	0.3506534759764146
GOTERM_BP_DIRECT	GO:0006281~DNA repair	7	11.11111111111111	2.2516342032514113E-4	DDB2, CHEK1, ATR, RRM2B, GADD45A, ATM, CDK2	63	235	16792	7.939479905437352	0.1669220762221847	0.003439883116870268	0.3456868444787209
GOTERM_CC_DIRECT	GO:0031264~death-inducing signaling complex	3	4.761904761904762	2.3654159949421927E-4	CASP3, CASP8, FAS	63	7	18224	123.97278911564625	0.02844897410011793	0.004114581638030357	0.2720077412855293
GOTERM_BP_DIRECT	GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	4	6.349206349206349	2.4165593011411443E-4	TNFRSF10B, CASP8, SERPINE1, FAS	63	33	16792	32.3078403078403	0.17799322622721314	0.0036231730658224937	0.3709633479609953
GOTERM_BP_DIRECT	GO:0043491~protein kinase B signaling	4	6.349206349206349	2.4165593011411443E-4	TSC2, IGF1, SESN2, PTEN	63	33	16792	32.3078403078403	0.17799322622721314	0.0036231730658224937	0.3709633479609953
INTERPRO	IPR011029:Death-like domain	5	7.936507936507936	2.4222292956408592E-4	TNFRSF10B, CASP9, CASP8, APAF1, FAS	61	94	18559	16.18329264039065	0.036619522945656735	0.007433603006593126	0.29018419185328215
BIOCARTA	h_hsp27Pathway:Stress Induction of HSP Regulation	5	7.936507936507936	2.438279612102328E-4	CASP3, CASP9, CYCS, APAF1, FAS	35	16	1625	14.50892857142857	0.018362501194607805	0.001234782667621781	0.25628263139224616
GOTERM_BP_DIRECT	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	4	6.349206349206349	2.6434616597969797E-4	CASP3, CASP9, BAX, FAS	63	34	16792	31.357609710550882	0.1929850467842399	0.003890830690502556	0.40572872133052273
GOTERM_BP_DIRECT	GO:0006260~DNA replication	6	9.523809523809524	2.660409412192647E-4	RRM2, IGF1, CHEK1, ATR, ATM, CDK2	63	155	16792	10.317665130568356	0.1940937906449386	0.003845940866935793	0.40832495540272795
KEGG_PATHWAY	hsa05212:Pancreatic cancer	6	9.523809523809524	2.697281529563142E-4	CCND1, CDKN2A, CASP9, TP53, CDK6, CDK4	63	65	6910	10.124542124542124	0.028190071865756283	0.001298930242079832	0.3022456278548358
GOTERM_BP_DIRECT	GO:0009636~response to toxic substance	5	7.936507936507936	2.7274312926446706E-4	CDKN1A, BAX, MDM2, FAS, CDK4	63	85	16792	15.678804855275441	0.19846356382438102	0.003873615803362429	0.4185914485347886
GOTERM_BP_DIRECT	GO:0001844~protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	3	4.761904761904762	2.7834603771005405E-4	BBC3, BAX, PMAIP1	63	7	16792	114.2312925170068	0.20209844925869835	0.0038850209295917537	0.4271732924307714
GAD_DISEASE	pancreas adenocarcinomas	3	4.761904761904762	2.814002629195705E-4	CDKN2A, TP53, CHEK2	58	6	12971	111.81896551724138	0.27690793152381565	0.00548016141569363	0.4516602159270411
GAD_DISEASE	Leukoplakia|Mouth Neoplasms	3	4.761904761904762	2.814002629195705E-4	TP53, MDM2, TP73	58	6	12971	111.81896551724138	0.27690793152381565	0.00548016141569363	0.4516602159270411
GAD_DISEASE	prostatic hyperplasia; prostate cancer	3	4.761904761904762	2.814002629195705E-4	CCND1, IGF1, IGFBP3	58	6	12971	111.81896551724138	0.27690793152381565	0.00548016141569363	0.4516602159270411
GAD_DISEASE	Narcolepsy	7	11.11111111111111	3.383343410433592E-4	RFWD2, CCND2, CASP8, MDM4, IGFBP3, PTEN, CCNG2	58	214	12971	7.315259426361585	0.32282605939206	0.006476057870553054	0.5428089944374381
GOTERM_BP_DIRECT	GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors	4	6.349206349206349	3.6876769655692893E-4	BID, TNFRSF10B, BAX, FAS	63	38	16792	28.056808688387633	0.25853384266135926	0.005057097729624482	0.5655744427212062
GOTERM_BP_DIRECT	GO:0006975~DNA damage induced protein phosphorylation	3	4.761904761904762	3.7024500997009447E-4	CHEK1, CHEK2, ATM	63	8	16792	99.95238095238095	0.2594219901625463	0.0049928988900326265	0.5678341533547959
GAD_DISEASE	Breast Neoplasms|Mammary Neoplasms|ovarian neoplasm|Ovarian Neoplasms	3	4.761904761904762	3.928478654113746E-4	TP53, CHEK2, PERP	58	7	12971	95.84482758620689	0.36405910859434853	0.007393022362716883	0.6300092267894519
GAD_DISEASE	Breast Neoplasms|Mammary Neoplasms	4	6.349206349206349	3.997740504882131E-4	CASP8, TP53, IGF1, IGFBP3	58	33	12971	27.107628004179727	0.3691150650879339	0.0074020140991163386	0.6410832680149858
BBID	46.P13K_PTEN	5	7.936507936507936	4.499710190095172E-4	BID, CASP3, BAX, CASP8, FAS	15	12	388	10.777777777777777	0.011633678738468878	0.0038930289198343404	0.3684139979256762
INTERPRO	IPR016129:Peptidase C14, ICE, catalytic subunit p20, active site	3	4.761904761904762	4.5487144993708854E-4	CASP3, CASP9, CASP8	61	10	18559	91.27377049180328	0.06766784662116376	0.011609770423417598	0.54430162525686
GOTERM_BP_DIRECT	GO:0032464~positive regulation of protein homooligomerization	3	4.761904761904762	4.7489695139530606E-4	BID, BBC3, FAS	63	9	16792	88.84656084656085	0.3197078275949429	0.006295394016435196	0.7277884990746886
GOTERM_BP_DIRECT	GO:0006469~negative regulation of protein kinase activity	5	7.936507936507936	4.8791379086872275E-4	CDKN2A, TSC2, SFN, GADD45B, GADD45A	63	99	16792	13.461600128266793	0.32685508732894086	0.006363451599613157	0.7476671419572312
GOTERM_CC_DIRECT	GO:0061700~GATOR2 complex	3	4.761904761904762	5.035488533775275E-4	SESN2, SESN1, SESN3	63	10	18224	86.78095238095237	0.05959856141114406	0.0076516301572766565	0.5782371763328742
GOTERM_CC_DIRECT	GO:0000781~chromosome, telomeric region	4	6.349206349206349	5.128527137896349E-4	CHEK1, CHEK2, ATM, CDK2	63	46	18224	25.15389924085576	0.060665920338419665	0.006929665109841943	0.5888922346417802
INTERPRO	IPR004038:Ribosomal protein L7Ae/L30e/S12e/Gadd45	3	4.761904761904762	5.547976193548434E-4	GADD45G, GADD45B, GADD45A	61	11	18559	82.97615499254843	0.08191246858417545	0.012134708023186946	0.6635094037280798
GAD_DISEASE	cervical cancer	5	7.936507936507936	5.687755652663591E-4	CDKN1A, CCND1, TP53, FAS, TP73	58	87	12971	12.852754657154183	0.48077390826318145	0.01034949790259121	0.9109356361713283
GAD_DISEASE	oral cancer	4	6.349206349206349	6.085794288590589E-4	CDKN1A, CCND1, SERPINE1, TP53	58	38	12971	23.540834845735027	0.5040583107365291	0.010897946780986989	0.9743921835152158
GAD_DISEASE	Carcinoma, Squamous Cell|Head and Neck Neoplasms|Squamous cell carcinoma	4	6.349206349206349	6.572462158203755E-4	BAX, CASP8, TP53, CHEK2	58	39	12971	22.937223695844384	0.5311144480050365	0.011584630253090644	1.0519264920533455
INTERPRO	IPR002138:Peptidase C14, caspase non-catalytic subunit p10	3	4.761904761904762	6.643726872387658E-4	CASP3, CASP9, CASP8	61	12	18559	76.06147540983606	0.09728410270807453	0.012711936519363976	0.7940773555458303
GAD_DISEASE	Chronic B-Cell Leukemias|Leukemia, Lymphocytic, Chronic, B-Cell	3	4.761904761904762	6.696570271550173E-4	BAX, TP53, MDM2	58	9	12971	74.54597701149424	0.5377749163086811	0.011624383094991253	1.0716898717812895
GAD_DISEASE	Type 2 Diabetes| edema | rosiglitazone	21	33.33333333333333	7.130982681157162E-4	BID, TP53, IGF1, CDK6, CDK4, PTEN, ATM, GTSE1, CDKN1A, CASP3, TNFRSF10B, CASP9, BAX, CASP8, SERPINE1, FAS, MDM4, APAF1, PERP, THBS1, IGFBP3	58	2198	12971	2.1366681309027014	0.560352603729838	0.012190493142767433	1.1408379635908794
GOTERM_BP_DIRECT	GO:0000185~activation of MAPKKK activity	3	4.761904761904762	7.220907151854218E-4	GADD45G, GADD45B, GADD45A	63	11	16792	72.6926406926407	0.44335473307961615	0.009255742405051004	1.1046548807273626
GOTERM_MF_DIRECT	GO:0032403~protein complex binding	6	9.523809523809524	7.559592833106843E-4	CDKN1A, CASP3, CCND1, CASP8, CDK4, ATM	60	206	16881	8.194660194174759	0.1153044608008641	0.015197302108702182	0.9109200824283015
GAD_DISEASE	Nasopharyngeal Neoplasms	4	6.349206349206349	7.618766988381825E-4	CDKN2A, TP53, MDM2, FAS	58	41	12971	21.81833473507149	0.5843935373432774	0.012829004572370906	1.2184275640244713
GAD_DISEASE_CLASS	REPRODUCTION	13	20.634920634920633	7.947566416290192E-4	STEAP3, RRM2, CASP8, SERPINE1, TP53, IGF1, MDM2, FAS, MDM4, THBS1, IGFBP3, PTEN, CDK2	58	960	12971	3.028430316091954	0.01420938732977517	0.0023823755125272905	0.5843523575241427
GOTERM_BP_DIRECT	GO:0006461~protein complex assembly	5	7.936507936507936	8.85713098606312E-4	CCNB1, TP53, MDM2, FAS, MDM4	63	116	16792	11.488779419813902	0.5125812264034515	0.011165813423506421	1.3533738984913168
GAD_DISEASE	Multiple Sclerosis	10	15.873015873015872	8.957828802846943E-4	CASP3, CASP9, BAX, CASP8, SERPINE1, TP53, DDB2, FAS, PMAIP1, SESN3	58	581	12971	3.8491898628998755	0.6438503788255174	0.014851001676534636	1.4311324723718766
BIOCARTA	h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	5	7.936507936507936	8.962618177192772E-4	TP53, CHEK1, CHEK2, ATR, ATM	35	22	1625	10.55194805194805	0.0658763306651855	0.004250095250389441	0.9391221995833754
INTERPRO	IPR015917:Peptidase C14, caspase precursor p45, core	3	4.761904761904762	9.122244352698057E-4	CASP3, CASP9, CASP8	61	14	18559	65.19555035128806	0.13111689359980216	0.015494995414182422	1.088833511406584
GOTERM_MF_DIRECT	GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process	3	4.761904761904762	9.137967812972892E-4	CASP3, CASP9, CASP8	60	13	16881	64.92692307692307	0.13765750115952424	0.01632120382075375	1.1001487621021155
SMART	SM00115:CASc	3	4.761904761904762	9.479847546148356E-4	CASP3, CASP9, CASP8	37	13	10057	62.72557172557173	0.029893965986415583	0.01006563234354263	0.8180575976079685
GAD_DISEASE	Wegener Granulomatosis	3	4.761904761904762	0.0010173231230280759	SERPINE1, TP53, MDM2	58	11	12971	60.992163009404386	0.6904243441801201	0.016611240073153066	1.6238226129931532
GOTERM_BP_DIRECT	GO:0032026~response to magnesium ion	3	4.761904761904762	0.0010191941549369298	CCND1, MDM2, THBS1	63	13	16792	61.509157509157504	0.5626353366372779	0.012642297892644927	1.55584241265192
GOTERM_BP_DIRECT	GO:0008340~determination of adult lifespan	3	4.761904761904762	0.0010191941549369298	BBC3, TP53, ATM	63	13	16792	61.509157509157504	0.5626353366372779	0.012642297892644927	1.55584241265192
GOTERM_BP_DIRECT	GO:0030308~negative regulation of cell growth	5	7.936507936507936	0.0010365456168505978	EI24, CDKN1A, CDKN2A, TP53, SESN2	63	121	16792	11.014036468581923	0.5687530903288122	0.012662697434431713	1.5821331337231626
INTERPRO	IPR001309:Peptidase C14, ICE, catalytic subunit p20	3	4.761904761904762	0.0010503792834988409	CASP3, CASP9, CASP8	61	15	18559	60.84918032786885	0.1494256255325953	0.01605407952161897	1.2527846506585116
UP_KEYWORDS	Mitosis	6	9.523809523809524	0.0011525384723455358	CCNB1, CCNB2, CHEK2, CCNG1, CCNG2, CDK2	63	262	20581	7.481279534714649	0.12923607566706097	0.010588495206512949	1.315075406019195
UP_KEYWORDS	Serine/threonine-protein kinase	7	11.11111111111111	0.0011644553807344093	CHEK1, CDK6, CHEK2, ATR, CDK4, ATM, CDK2	63	393	20581	5.818772971444727	0.130481845601353	0.009937158769132814	1.3285900419624852
GOTERM_BP_DIRECT	GO:0010243~response to organonitrogen compound	3	4.761904761904762	0.001186235009122074	CDKN1A, CCND1, TP73	63	14	16792	57.1156462585034	0.618104261994173	0.014264561446655999	1.8086682116814412
GAD_DISEASE	Adenocarcinoma|Neoplasms, Prostatic|Prostatic Neoplasms	3	4.761904761904762	0.00121734552100479	CASP3, CASP9, CASP8	58	12	12971	55.90948275862069	0.7541998140453983	0.01956986652896553	1.9401696182244743
GAD_DISEASE	Endometrial Neoplasms|	3	4.761904761904762	0.00121734552100479	CASP3, CCND1, CASP8	58	12	12971	55.90948275862069	0.7541998140453983	0.01956986652896553	1.9401696182244743
GAD_DISEASE	pharmacogenetic studies	5	7.936507936507936	0.0012356537353524156	CDKN1A, CCND1, BAX, SERPINE1, TP53	58	107	12971	10.45037060908798	0.7593359468246312	0.01958829123850503	1.9690774113195975
BIOCARTA	h_caspasePathway:Caspase Cascade in Apoptosis	5	7.936507936507936	0.0012637712188775878	CASP3, CASP9, CYCS, CASP8, APAF1	35	24	1625	9.672619047619047	0.09163350620423671	0.00563742353582064	1.321893474597824
GAD_DISEASE	Carcinoma, Squamous Cell|Esophageal Neoplasms	4	6.349206349206349	0.0012844350109524148	CCND1, CDKN2A, TP53, FAS	58	49	12971	18.25615763546798	0.7725034524992949	0.020078163056753806	2.0460616962276412
KEGG_PATHWAY	hsa05134:Legionellosis	5	7.936507936507936	0.0013287573339876458	CASP3, CASP9, CYCS, CASP8, APAF1	63	54	6910	10.155790711346265	0.13146025971727782	0.006109172953833064	1.4809176026690851
GOTERM_BP_DIRECT	GO:0030330~DNA damage response, signal transduction by p53 class mediator	3	4.761904761904762	0.0013654818525866074	TP53, MDM4, SESN2	63	15	16792	53.3079365079365	0.6698349317188259	0.016164438292415317	2.0792931424013394
GOTERM_MF_DIRECT	GO:0005123~death receptor binding	3	4.761904761904762	0.001396394646798336	BID, CASP3, CASP8	60	16	16881	52.753125000000004	0.20258020772305296	0.02238309887833878	1.6766726685743083
GAD_DISEASE	Pancreatic Neoplasms	6	9.523809523809524	0.0014121512019736851	CDKN1A, CDKN2A, TP53, ATR, PTEN, ATM	58	189	12971	7.099616858237548	0.803667947874686	0.02175907634273966	2.2473488479373582
GOTERM_MF_DIRECT	GO:0016301~kinase activity	6	9.523809523809524	0.0015207199617661626	CCNE1, CDKN1A, CDKN2A, CHEK1, ATR, CDK2	60	241	16881	7.004564315352697	0.21850313735278637	0.022163796412974612	1.8246946393578267
KEGG_PATHWAY	hsa05016:Huntington's disease	8	12.698412698412698	0.0015468871821906	CASP3, CASP9, BBC3, BAX, CYCS, CASP8, TP53, APAF1	63	192	6910	4.57010582010582	0.1513402968647828	0.0068140530793814325	1.7221082746934457
GOTERM_BP_DIRECT	GO:1900745~positive regulation of p38MAPK cascade	3	4.761904761904762	0.0015568452081040007	GADD45G, GADD45B, GADD45A	63	16	16792	49.976190476190474	0.7173611437391276	0.018146169772074283	2.3674416867141668
GOTERM_BP_DIRECT	GO:0097194~execution phase of apoptosis	3	4.761904761904762	0.0015568452081040007	CASP3, BBC3, CASP8	63	16	16792	49.976190476190474	0.7173611437391276	0.018146169772074283	2.3674416867141668
UP_KEYWORDS	Kinase	9	14.285714285714285	0.0015676701942775803	CDKN1A, CDKN2A, CHEK1, CDK6, CHEK2, ATR, CDK4, ATM, CDK2	63	735	20581	4.00019436345967	0.1716073590851559	0.012472764367162603	1.7848702942025785
GOTERM_CC_DIRECT	GO:0005741~mitochondrial outer membrane	5	7.936507936507936	0.0016571910640643857	BID, BBC3, BAX, CASP8, PMAIP1	63	149	18224	9.707041653350378	0.183186936166839	0.02003115813086198	1.8914997861488425
GAD_DISEASE	Uterine Cervical Neoplasms	3	4.761904761904762	0.0016690134075866294	CCND1, TP53, FAS	58	14	12971	47.922413793103445	0.854023516474469	0.02533110762678603	2.651002569449712
GAD_DISEASE	Lupus Erythematosus, Systemic|Lupus Nephritis	3	4.761904761904762	0.0016690134075866294	CDKN1A, TP53, MDM2	58	14	12971	47.922413793103445	0.854023516474469	0.02533110762678603	2.651002569449712
GAD_DISEASE	Carcinoma, Transitional Cell|Urinary Bladder Neoplasms	3	4.761904761904762	0.0016690134075866294	CCND1, TP53, MDM2	58	14	12971	47.922413793103445	0.854023516474469	0.02533110762678603	2.651002569449712
GOTERM_BP_DIRECT	GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors	3	4.761904761904762	0.00176023607442654	TNFRSF10B, CASP8, FAS	63	17	16792	47.03641456582632	0.7604059740505827	0.02020465630715118	2.6728316409801667
GAD_DISEASE_CLASS	NORMALVARIATION	9	14.285714285714285	0.0017843131373403841	CCND1, TNFRSF10B, SERPINE1, TP53, IGF1, CDK6, FAS, IGFBP3, TP73	58	517	12971	3.8931167878343227	0.0316351238556446	0.004581803446655486	1.3078061079408676
UP_KEYWORDS	DNA repair	6	9.523809523809524	0.0018853942822571997	DDB2, CHEK1, CHEK2, ATR, RRM2B, CDK2	63	293	20581	6.689744839915488	0.2026494540061492	0.014054109884369725	2.1430509663676656
GAD_DISEASE	breast cancer; ovarian cancer	3	4.761904761904762	0.0019203595042604498	MDM2, CHEK2, ATR	58	15	12971	44.727586206896554	0.8907789025135968	0.02871621472505781	3.0444742103167055
KEGG_PATHWAY	hsa05205:Proteoglycans in cancer	8	12.698412698412698	0.001955262909145994	CDKN1A, CASP3, CCND1, TP53, MDM2, IGF1, FAS, THBS1	63	200	6910	4.387301587301587	0.18735486634088916	0.00826409326223665	2.172212206314772
GOTERM_BP_DIRECT	GO:0009749~response to glucose	4	6.349206349206349	0.0020250371849141503	CASP3, THBS1, SESN2, PTEN	63	68	16792	15.678804855275441	0.806788583975307	0.022888502211334205	3.069090408323394
GAD_DISEASE	Bone Mineral Density	8	12.698412698412698	0.002053868533913201	CDKN1A, CASP3, CCND1, BAX, CASP8, IGF1, CDK6, IGFBP3	58	411	12971	4.353049752496015	0.9063779800904769	0.030291342870245486	3.2528699078646417
GAD_DISEASE	meningioma	3	4.761904761904762	0.0021885156805296945	CCND1, CDKN2A, PTEN	58	16	12971	41.932112068965516	0.9198562118574702	0.03184019176264674	3.4626165867218117
GAD_DISEASE	Esophageal Neoplasms|Head and Neck Neoplasms|Laryngeal Neoplasms|Mouth Neoplasms|Pharyngeal Neoplasms	4	6.349206349206349	0.0021971104660162993	CDKN1A, CDKN2A, TP53, MDM2	58	59	12971	15.16189362945646	0.920647542165552	0.03156520560078413	3.475990629180048
GOTERM_BP_DIRECT	GO:0008637~apoptotic mitochondrial changes	3	4.761904761904762	0.002202746700738183	BID, CDKN2A, BAX	63	19	16792	42.08521303258145	0.8327721444632047	0.024532914846187137	3.3341755083212687
GAD_DISEASE	Colon Cancer	3	4.761904761904762	0.0024733345911291445	BAX, IGF1, IGFBP3	58	17	12971	39.46551724137931	0.9423180444422605	0.03503180432659381	3.9048890984780815
GAD_DISEASE	Gastrointestinal Stromal Tumors	3	4.761904761904762	0.0024733345911291445	CASP3, CASP9, CASP8	58	17	12971	39.46551724137931	0.9423180444422605	0.03503180432659381	3.9048890984780815
GAD_DISEASE_CLASS	IMMUNE	24	38.095238095238095	0.002555747879050229	BID, TP53, IGF1, CDK6, PMAIP1, CCNG2, PTEN, CDK2, TP73, SESN3, CASP3, CDKN1A, TNFRSF10B, CDKN2A, CCND3, CASP9, BAX, CASP8, SERPINE1, DDB2, MDM2, FAS, RCHY1, IGFBP3	58	2986	12971	1.7974917430768875	0.04501758167599712	0.005741249274945792	1.8686326891237837
GOTERM_BP_DIRECT	GO:1900182~positive regulation of protein localization to nucleus	3	4.761904761904762	0.0026923111548071486	CDKN2A, SESN2, GTSE1	63	21	16792	38.07709750566893	0.8876806263923267	0.029506726210946632	4.060945879340572
GAD_DISEASE	Carcinoma, Squamous Cell|Esophageal Neoplasms|	3	4.761904761904762	0.0027746698213502717	CCND1, CDKN2A, TP53	58	18	12971	37.27298850574712	0.9592729325109091	0.03874621370668552	4.37073933237373
BBID	86.Apoptosis_Nematode&_Vert	4	6.349206349206349	0.002778900157070166	CASP3, CASP9, CASP8, APAF1	15	9	388	11.496296296296295	0.06979657497985259	0.017925389141928205	2.256244143978614
GAD_DISEASE	diabetes, type 2	8	12.698412698412698	0.0029728565051524553	CDKN2A, CASP9, CCND2, SERPINE1, IGF1, CHEK2, CDK4, PTEN	58	439	12971	4.0754064880999135	0.9676075990431187	0.04096452436631892	4.675971254743116
GAD_DISEASE	Brain Neoplasms|Glioma	4	6.349206349206349	0.003026294302343551	CDKN2A, TP53, PTEN, ATM	58	66	12971	13.553814002089863	0.9695471890324172	0.04119464609046797	4.758115519548555
GOTERM_BP_DIRECT	GO:0032496~response to lipopolysaccharide	5	7.936507936507936	0.0031506267187161674	CASP3, TNFRSF10B, CASP9, CASP8, FAS	63	164	16792	8.126209833526906	0.9226327657726866	0.03399249396104176	4.736693529026792
GOTERM_MF_DIRECT	GO:0031625~ubiquitin protein ligase binding	6	9.523809523809524	0.0032464892311401977	BID, CDKN1A, CASP8, TP53, MDM2, CHEK2	60	287	16881	5.881881533101045	0.40950069643947895	0.042949291405627754	3.858396353220339
GAD_DISEASE	Mouth Neoplasms	3	4.761904761904762	0.003426308206894514	CCND1, TP53, ATM	58	20	12971	33.54568965517241	0.9808199488481495	0.04597943778199687	5.370909436541371
GAD_DISEASE	Colonic Neoplasms|Rectal Neoplasms	3	4.761904761904762	0.003426308206894514	TSC2, TP53, PTEN	58	20	12971	33.54568965517241	0.9808199488481495	0.04597943778199687	5.370909436541371
GAD_DISEASE	Leukemia, Myeloid|Myeloid Leukemia	3	4.761904761904762	0.003426308206894514	TP53, MDM2, ATM	58	20	12971	33.54568965517241	0.9808199488481495	0.04597943778199687	5.370909436541371
GOTERM_CC_DIRECT	GO:0000785~chromatin	4	6.349206349206349	0.003458682384051673	CCND2, CHEK1, CDK4, TP73	63	89	18224	13.000891742464775	0.3447186865097809	0.03769749421018431	3.91059685219024
GOTERM_BP_DIRECT	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	3	4.761904761904762	0.0035133652513847837	CCND1, CCND3, CCND2	63	24	16792	33.317460317460316	0.9424071216328227	0.037342976452684584	5.268363268905086
KEGG_PATHWAY	hsa05010:Alzheimer's disease	7	11.11111111111111	0.003766275539513921	BID, CASP3, CASP9, CYCS, CASP8, APAF1, FAS	63	168	6910	4.57010582010582	0.3296658075486605	0.015266077459365035	4.1457364349820285
KEGG_PATHWAY	hsa05202:Transcriptional misregulation in cancer	7	11.11111111111111	0.003766275539513921	CDKN1A, CCND2, TP53, MDM2, IGF1, IGFBP3, ATM	63	168	6910	4.57010582010582	0.3296658075486605	0.015266077459365035	4.1457364349820285
GOTERM_BP_DIRECT	GO:0071158~positive regulation of cell cycle arrest	3	4.761904761904762	0.003809828538204167	CDKN2A, TP53, TP73	63	25	16792	31.984761904761903	0.9547553878855262	0.039914102704871834	5.700831026187403
GAD_DISEASE	Chromosome Aberrations|DNA Damage	3	4.761904761904762	0.004524030784814145	CDKN1A, CCND1, TP53	58	23	12971	29.17016491754123	0.9946116068155161	0.05960289036597699	7.033603471425898
GOTERM_CC_DIRECT	GO:0016605~PML body	4	6.349206349206349	0.004533045077192722	TP53, CHEK2, ATR, PTEN	63	98	18224	11.806932296728215	0.4255192896604839	0.045140175488337486	5.096597546250936
GAD_DISEASE_CLASS	DEVELOPMENTAL	15	23.809523809523807	0.004620406206537798	BID, TP53, IGF1, CDK6, ATR, PTEN, TP73, CASP3, TNFRSF10B, CASP9, SERPINE1, TSC2, CASP8, APAF1, IGFBP3	58	1502	12971	2.23340144175582	0.07998015542420578	0.009219464259562216	3.35609107985968
GAD_DISEASE	autism	7	11.11111111111111	0.004636786406685344	CASP3, CASP9, TSC2, SERPINE1, IGF1, APAF1, PTEN	58	357	12971	4.385057471264368	0.9952708047720965	0.0603575201615677	7.202831107580609
KEGG_PATHWAY	hsa05152:Tuberculosis	7	11.11111111111111	0.004862227260912903	BID, CASP3, CASP9, BAX, CYCS, CASP8, APAF1	63	177	6910	4.337727558066541	0.4034863489871062	0.018953384252883843	5.322349610373367
GAD_DISEASE	esophageal cancer 	4	6.349206349206349	0.005203210293265515	TP53, MDM2, FAS, PTEN	58	80	12971	11.181896551724138	0.9975452904645418	0.06674569649460471	8.048578218207037
UP_SEQ_FEATURE	zinc finger region:RING-type	5	7.936507936507936	0.00558238557082247	RFWD2, MDM2, SIAH1, MDM4, RCHY1	63	230	20063	6.923050379572118	0.7286484045651904	0.3525928972062248	6.939232700637565
GOTERM_BP_DIRECT	GO:0071479~cellular response to ionizing radiation	3	4.761904761904762	0.005821869952178476	CDKN1A, TP53, GADD45A	63	31	16792	25.794162826420887	0.9912204857304971	0.05964502938840066	8.587491460375386
GOTERM_BP_DIRECT	GO:0048147~negative regulation of fibroblast proliferation	3	4.761904761904762	0.005821869952178476	BAX, TP53, PMAIP1	63	31	16792	25.794162826420887	0.9912204857304971	0.05964502938840066	8.587491460375386
GOTERM_BP_DIRECT	GO:0010468~regulation of gene expression	4	6.349206349206349	0.006010165813757021	IGF1, CDK6, CDK4, TP73	63	100	16792	10.6615873015873	0.992470682952634	0.06075494388176261	8.8533672738634
UP_KEYWORDS	Host-virus interaction	6	9.523809523809524	0.006033683300065831	BAX, TSC2, CASP8, TP53, MDM2, TP73	63	385	20581	5.091156462585034	0.5162732715416947	0.04182008339540111	6.711411453450388
UP_SEQ_FEATURE	region of interest:Region II	2	3.1746031746031744	0.00617113514416832	MDM2, MDM4	63	2	20063	318.46031746031747	0.7636235186796851	0.3027298623102599	7.6445842545780796
GAD_DISEASE	Carcinoma, Squamous Cell|Head and Neck Neoplasms	3	4.761904761904762	0.006206217175718074	CASP3, CCND1, MDM2	58	27	12971	24.84865900383142	0.9992320917339441	0.07826561717029801	9.528495051197105
GAD_DISEASE	Carcinoma, Squamous Cell|Mouth Neoplasms|Squamous cell carcinoma	3	4.761904761904762	0.006206217175718074	CDKN1A, CCND1, TP53	58	27	12971	24.84865900383142	0.9992320917339441	0.07826561717029801	9.528495051197105
INTERPRO	IPR016495:p53 negative regulator Mdm2/Mdm4	2	3.1746031746031744	0.006455587406913257	MDM2, MDM4	61	2	18559	304.24590163934425	0.6311566619303854	0.08668204642448141	7.475094624910805
INTERPRO	IPR012348:Ribonucleotide reductase-related	2	3.1746031746031744	0.006455587406913257	RRM2, RRM2B	61	2	18559	304.24590163934425	0.6311566619303854	0.08668204642448141	7.475094624910805
INTERPRO	IPR000358:Ribonucleotide reductase small subunit	2	3.1746031746031744	0.006455587406913257	RRM2, RRM2B	61	2	18559	304.24590163934425	0.6311566619303854	0.08668204642448141	7.475094624910805
GOTERM_BP_DIRECT	GO:0006468~protein phosphorylation	7	11.11111111111111	0.006608669568504682	CCNE1, CCND1, CDK6, CHEK2, CDK4, IGFBP3, ATM	63	456	16792	4.091617933723197	0.9953802720018801	0.06580361509005617	9.693667610539746
GOTERM_CC_DIRECT	GO:0043293~apoptosome	2	3.1746031746031744	0.00679282594786332	CASP9, APAF1	63	2	18224	289.26984126984127	0.5646270543798797	0.06196269422357914	7.547684718241642
GOTERM_CC_DIRECT	GO:0097135~cyclin E2-CDK2 complex	2	3.1746031746031744	0.00679282594786332	CCNE2, CDK2	63	2	18224	289.26984126984127	0.5646270543798797	0.06196269422357914	7.547684718241642
GOTERM_CC_DIRECT	GO:0097134~cyclin E1-CDK2 complex	2	3.1746031746031744	0.00679282594786332	CCNE1, CDK2	63	2	18224	289.26984126984127	0.5646270543798797	0.06196269422357914	7.547684718241642
GAD_DISEASE	Colonic Neoplasms|Microsatellite Instability	3	4.761904761904762	0.007138476575196637	IGF1, IGFBP3, GADD45A	58	29	12971	23.134958382877524	0.9997395285166042	0.08856092732091403	10.883968676073774
INTERPRO	IPR011009:Protein kinase-like domain	7	11.11111111111111	0.007226900937196985	CHEK1, CDK6, CHEK2, ATR, CDK4, ATM, CDK2	61	531	18559	4.010774597882128	0.6727345910299638	0.0888811984920993	8.333092605189929
GOTERM_BP_DIRECT	GO:0008284~positive regulation of cell proliferation	7	11.11111111111111	0.00732181168630111	CCND2, MDM2, IGF1, THBS1, CDK4, PTEN, CDK2	63	466	16792	4.003814973772055	0.9974196607413615	0.07179060446946472	10.685462555198432
GOTERM_BP_DIRECT	GO:1904884~positive regulation of telomerase catalytic core complex assembly	2	3.1746031746031744	0.007371055281912429	ATR, ATM	63	2	16792	266.53968253968253	0.9975214126839452	0.07139785661249787	10.753570286137915
GOTERM_BP_DIRECT	GO:0009186~deoxyribonucleoside diphosphate metabolic process	2	3.1746031746031744	0.007371055281912429	RRM2, RRM2B	63	2	16792	266.53968253968253	0.9975214126839452	0.07139785661249787	10.753570286137915
GOTERM_BP_DIRECT	GO:0097694~establishment of RNA localization to telomere	2	3.1746031746031744	0.007371055281912429	ATR, ATM	63	2	16792	266.53968253968253	0.9975214126839452	0.07139785661249787	10.753570286137915
GOTERM_BP_DIRECT	GO:0097695~establishment of macromolecular complex localization to telomere	2	3.1746031746031744	0.007371055281912429	ATR, ATM	63	2	16792	266.53968253968253	0.9975214126839452	0.07139785661249787	10.753570286137915
GOTERM_BP_DIRECT	GO:0072593~reactive oxygen species metabolic process	3	4.761904761904762	0.007379305218427593	PMAIP1, SESN2, SESN1	63	35	16792	22.846258503401362	0.9975380632006099	0.07063501970822272	10.764975841185919
GOTERM_BP_DIRECT	GO:0031648~protein destabilization	3	4.761904761904762	0.007379305218427593	CDKN2A, MDM2, SIAH1	63	35	16792	22.846258503401362	0.9975380632006099	0.07063501970822272	10.764975841185919
UP_SEQ_FEATURE	short sequence motif:Nuclear export signal	3	4.761904761904762	0.0074718308973726905	RFWD2, TP53, MDM2	63	42	20063	22.74716553287982	0.8257864043655954	0.29495569508788577	9.185440784511712
UP_KEYWORDS	Polymorphism	47	74.60317460317461	0.0074784326690085084	STEAP3, BID, CHEK1, CHEK2, RRM2B, SFN, CCNG1, SESN2, CCNG2, PTEN, SESN1, GTSE1, SESN3, CCNE2, CASP3, TP53I3, CDKN2A, CASP9, CASP8, SERPINE1, FAS, THBS1, CYCS, TP53, IGF1, CDK6, ATR, CDK4, ATM, CDK2, PPM1D, CCNB3, CDKN1A, EI24, TNFRSF10B, CCNB2, CCND3, SERPINB5, CCND2, BAX, CD82, TSC2, GADD45G, DDB2, MDM4, PERP, IGFBP3	63	12043	20581	1.274938085616488	0.5937491129490335	0.0488120250435522	8.256170189890144
KEGG_PATHWAY	hsa04914:Progesterone-mediated oocyte maturation	5	7.936507936507936	0.007506813203124332	CCNB1, CCNB3, CCNB2, IGF1, CDK2	63	87	6910	6.303594234628717	0.5500972812122706	0.02812283267651372	8.107599526300335
UP_KEYWORDS	Disease mutation	16	25.396825396825395	0.0075703160521419545	CYCS, TP53, CDK6, RRM2B, ATR, CHEK2, CDK4, PTEN, ATM, EI24, CDKN2A, CCND2, CASP8, TSC2, DDB2, FAS	63	2550	20581	2.049772798008092	0.5982374194959227	0.046860893447643215	8.353619663053935
GAD_DISEASE_CLASS	AGING	11	17.46031746031746	0.007686846770998762	CDKN2A, TNFRSF10B, CASP9, TSC2, CASP8, SERPINE1, TP53, FAS, PERP, SESN1, GTSE1	58	948	12971	2.594954895969736	0.12968300479294692	0.01379375925431281	5.5292967038808705
UP_KEYWORDS	Oxidoreductase	7	11.11111111111111	0.00802239326944653	STEAP3, TP53I3, RRM2, RRM2B, SESN2, SESN1, SESN3	63	582	20581	3.9291714394807173	0.6196142834382006	0.04717924200950718	8.83170797763243
GAD_DISEASE	Hepatopulmonary Syndrome|Liver Cirrhosis	4	6.349206349206349	0.00812994394050687	CDKN2A, BAX, SERPINE1, THBS1	58	94	12971	9.51650770359501	0.9999176040539112	0.09921493690678962	12.304616654956668
GOTERM_MF_DIRECT	GO:0004672~protein kinase activity	6	9.523809523809524	0.008279134399018583	CCND1, CHEK1, CHEK2, ATR, CDK4, CDK2	60	359	16881	4.702228412256267	0.7399295382074639	0.09841432606415235	9.57041126568785
GAD_DISEASE	Breast Neoplasms|Neoplasms	2	3.1746031746031744	0.008769863048450694	FAS, ATM	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Fetal Growth Retardation|	2	3.1746031746031744	0.008769863048450694	IGF1, IGFBP3	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Melanoma|Neoplasms, Second Primary	2	3.1746031746031744	0.008769863048450694	CDKN2A, CDK4	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	colorectal cancer; esophageal cancer; stomach cancer	2	3.1746031746031744	0.008769863048450694	TP53, TP73	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	insulin-like growth factor-1; Insulin-like growth factor-3	2	3.1746031746031744	0.008769863048450694	IGF1, IGFBP3	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Brain Neoplasms|Oligodendroglioma	2	3.1746031746031744	0.008769863048450694	TP53, MDM2	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	squamous cell carcinoma	2	3.1746031746031744	0.008769863048450694	CCND1, TP53	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	ovarian cancer peritoneal cancer	2	3.1746031746031744	0.008769863048450694	TP53, MDM2	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	breast cancer; insulin-like growth factor	2	3.1746031746031744	0.008769863048450694	IGF1, IGFBP3	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	insulin-like growth factors	2	3.1746031746031744	0.008769863048450694	IGF1, IGFBP3	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	laryngeal squamous cell carcinoma	2	3.1746031746031744	0.008769863048450694	CCND1, TP53	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Adenocarcinoma|Aneuploidy|Barrett Esophagus|Esophageal Neoplasms|Oesophageal neoplasm	2	3.1746031746031744	0.008769863048450694	CDKN2A, TP53	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Li-Fraumeni Syndrome	2	3.1746031746031744	0.008769863048450694	TP53, MDM2	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	psoriasis, psoriatic arthritis, and SAPHO syndrome	2	3.1746031746031744	0.008769863048450694	TP53, MDM2	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	IGF-I levels; IGFBP-3 levels	2	3.1746031746031744	0.008769863048450694	IGF1, IGFBP3	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	DNA Damage|Lung Neoplasms	2	3.1746031746031744	0.008769863048450694	TP53, MDM2	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Adenocarcinoma|Cervical Neoplasm|Papillomavirus Infections|Uterine Cervical Neoplasms	2	3.1746031746031744	0.008769863048450694	CDKN1A, TP53	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Adenocarcinoma|Barrett Esophagus|Esophageal Neoplasms	2	3.1746031746031744	0.008769863048450694	IGF1, IGFBP3	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	esophageal cancer; stomach cancer; Barret's esophagus	2	3.1746031746031744	0.008769863048450694	CCND1, CDKN2A	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Carcinoma|Choroid Plexus Neoplasms|Choroid Plexus Papilloma|Papilloma, Choroid Plexus	2	3.1746031746031744	0.008769863048450694	TP53, MDM2	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Lymphoma, B-Cell|Lymphoma, Non-Hodgkin	2	3.1746031746031744	0.008769863048450694	TP53, MDM2	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Adenocarcinoma|Barrett Esophagus|Carcinoma, Squamous Cell|Cell Transformation, Neoplastic|Esophageal Neoplasms|Oesophageal neoplasm|Squamous cell carcinoma	2	3.1746031746031744	0.008769863048450694	TP53, CHEK2	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Leukemia, Myeloid|Neoplasms, Second Primary	2	3.1746031746031744	0.008769863048450694	TP53, MDM2	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
GAD_DISEASE	Colonic Neoplasms|DNA Damage|Microsatellite Instability	2	3.1746031746031744	0.008769863048450694	CHEK1, ATR	58	2	12971	223.63793103448276	0.9999608238886053	0.10551788177163457	13.210232173321423
UP_SEQ_FEATURE	region of interest:Interaction with USP7	2	3.1746031746031744	0.009242636545790692	TP53, MDM2	63	3	20063	212.3068783068783	0.8850833543372382	0.30273613840493385	11.245116498593378
PIR_SUPERFAMILY	PIRSF006748:p53 negative regulator Mdm2/Mdm4	2	3.1746031746031744	0.00943669237642246	MDM2, MDM4	9	2	1692	188.0	0.0904588166282706	0.0904588166282706	5.534317452083803
GOTERM_BP_DIRECT	GO:0007346~regulation of mitotic cell cycle	3	4.761904761904762	0.0095600549292446	CDKN1A, RPRM, TP73	63	40	16792	19.99047619047619	0.9995863552256331	0.08959113825219911	13.732537376016795
GAD_DISEASE	Endometriosis	4	6.349206349206349	0.009627622613380618	SERPINE1, TP53, FAS, PTEN	58	100	12971	8.94551724137931	0.9999855491382346	0.11408888731176492	14.410384036134428
INTERPRO	IPR011615:p53, DNA-binding domain	2	3.1746031746031744	0.009667995918692399	TP53, TP73	61	3	18559	202.8306010928962	0.7760013603139178	0.10871032516969903	11.000696372162167
INTERPRO	IPR010991:p53, tetramerisation domain	2	3.1746031746031744	0.009667995918692399	TP53, TP73	61	3	18559	202.8306010928962	0.7760013603139178	0.10871032516969903	11.000696372162167
INTERPRO	IPR002117:p53 tumour suppressor family	2	3.1746031746031744	0.009667995918692399	TP53, TP73	61	3	18559	202.8306010928962	0.7760013603139178	0.10871032516969903	11.000696372162167
GOTERM_MF_DIRECT	GO:0004674~protein serine/threonine kinase activity	6	9.523809523809524	0.0099896941425442	CHEK1, CHEK2, ATR, CDK4, ATM, CDK2	60	376	16881	4.489627659574468	0.8033771798519078	0.10968174118244123	11.439841360282244
GOTERM_CC_DIRECT	GO:0005971~ribonucleoside-diphosphate reductase complex	2	3.1746031746031744	0.010172194008120129	RRM2, RRM2B	63	3	18224	192.84656084656083	0.712738603180864	0.08524346841798336	11.105420009893653
GOTERM_CC_DIRECT	GO:0016942~insulin-like growth factor binding protein complex	2	3.1746031746031744	0.010172194008120129	IGF1, IGFBP3	63	3	18224	192.84656084656083	0.712738603180864	0.08524346841798336	11.105420009893653
GOTERM_CC_DIRECT	GO:0097129~cyclin D2-CDK4 complex	2	3.1746031746031744	0.010172194008120129	CCND2, CDK4	63	3	18224	192.84656084656083	0.712738603180864	0.08524346841798336	11.105420009893653
GOTERM_MF_DIRECT	GO:0004748~ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor	2	3.1746031746031744	0.010449174175503239	RRM2, RRM2B	60	3	16881	187.56666666666666	0.8176217252561474	0.10724654377632448	11.935919566527097
GOTERM_BP_DIRECT	GO:0097191~extrinsic apoptotic signaling pathway	3	4.761904761904762	0.01050310586014904	BAX, CASP8, FAS	63	42	16792	19.038548752834465	0.9998089675769481	0.09691741948270882	14.987040230049187
GAD_DISEASE	nasopharyngeal cancer	3	4.761904761904762	0.010861521257664672	CCND1, MDM2, FAS	58	36	12971	18.63649425287356	0.9999965630318205	0.12652757514633917	16.109545246741142
GOTERM_BP_DIRECT	GO:0009263~deoxyribonucleotide biosynthetic process	2	3.1746031746031744	0.011036510586842284	RRM2, RRM2B	63	3	16792	177.6931216931217	0.9998766356369923	0.10047342843470097	15.689033910831029
GOTERM_BP_DIRECT	GO:0018105~peptidyl-serine phosphorylation	4	6.349206349206349	0.011067109010269915	CHEK2, ATR, ATM, CDK2	63	125	16792	8.52926984126984	0.9998796926598149	0.09962795704368144	15.729138503883256
KEGG_PATHWAY	hsa04390:Hippo signaling pathway	6	9.523809523809524	0.011099827445738304	CCND1, CCND3, CCND2, BBC3, SERPINE1, TP73	63	151	6910	4.358246609902238	0.693690840775267	0.03997757287059167	11.772174239022092
KEGG_PATHWAY	hsa04932:Non-alcoholic fatty liver disease (NAFLD)	6	9.523809523809524	0.011099827445738304	BID, CASP3, BAX, CYCS, CASP8, FAS	63	151	6910	4.358246609902238	0.693690840775267	0.03997757287059167	11.772174239022092
KEGG_PATHWAY	hsa05213:Endometrial cancer	4	6.349206349206349	0.011125647482356567	CCND1, CASP9, TP53, PTEN	63	52	6910	8.437118437118437	0.6945374345367896	0.038759782217186456	11.798019703800755
BBID	38.Cell_cycle_arrest_and_apoptosis_ceramide	3	4.761904761904762	0.011383144258810771	CASP3, TP53, FAS	15	5	388	15.520000000000001	0.2574455901242324	0.05779445383929249	8.961348106627941
BBID	4.cyclins_&_p27_cell_cycle	3	4.761904761904762	0.011383144258810771	CDK6, CDK4, CDK2	15	5	388	15.520000000000001	0.2574455901242324	0.05779445383929249	8.961348106627941
BBID	157.14-3-3_Cell_Cycle	3	4.761904761904762	0.011383144258810771	CDKN1A, TP53, CDK2	15	5	388	15.520000000000001	0.2574455901242324	0.05779445383929249	8.961348106627941
GAD_DISEASE	Colonic Neoplasms	3	4.761904761904762	0.011450049287385985	TP53, IGF1, IGFBP3	58	37	12971	18.132805219012116	0.9999982685544219	0.13162666919051202	16.90879698325064
GOTERM_BP_DIRECT	GO:0001934~positive regulation of protein phosphorylation	4	6.349206349206349	0.011551221719263146	CCND1, CCND3, CCND2, CHEK2	63	127	16792	8.394950631171104	0.9999191218840139	0.10264647116281922	16.361284300926116
GOTERM_BP_DIRECT	GO:0045893~positive regulation of transcription, DNA-templated	7	11.11111111111111	0.011644552940513296	CCNE1, CDKN2A, TP53, IGF1, CHEK2, CDK2, TP73	63	515	16792	3.6228694714131606	0.9999250842988817	0.10232290071170635	16.482643644596664
UP_SEQ_FEATURE	region of interest:Oligomerization	2	3.1746031746031744	0.012304797888295138	TP53, TP73	63	4	20063	159.23015873015873	0.9441342054878172	0.33775169680262174	14.70544914137939
GOTERM_BP_DIRECT	GO:0071230~cellular response to amino acid stimulus	3	4.761904761904762	0.013032179536264149	SESN2, SESN1, SESN3	63	47	16792	17.01317122593718	0.9999760267287547	0.11266661115831533	18.267675999937016
GAD_DISEASE	Chagas Disease|Esophageal Neoplasms	2	3.1746031746031744	0.013126414656763464	CDKN2A, TP53	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	Carcinoma, Endometrioid|Endometrial Neoplasms	2	3.1746031746031744	0.013126414656763464	TP53, PTEN	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	Infertility, Female|Recurrence	2	3.1746031746031744	0.013126414656763464	SERPINE1, TP53	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	atherosclerosis, generalized myocardial infarct	2	3.1746031746031744	0.013126414656763464	CDKN1A, CDKN2A	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	DNA Damage|Leukemia, Lymphocytic, Chronic|Leukemia, Lymphocytic, Chronic, B-Cell	2	3.1746031746031744	0.013126414656763464	CHEK2, ATM	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	Breast Diseases	2	3.1746031746031744	0.013126414656763464	IGF1, IGFBP3	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	breast cancer prostate cancer	2	3.1746031746031744	0.013126414656763464	IGFBP3, PTEN	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	pancreatic adenocarcinoma	2	3.1746031746031744	0.013126414656763464	TP53, MDM2	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	Carcinoma, Squamous Cell|Skin Neoplasms	2	3.1746031746031744	0.013126414656763464	TP53, PTEN	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	growth response to growth hormone therapy	2	3.1746031746031744	0.013126414656763464	IGF1, IGFBP3	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	insulin-like growth factor	2	3.1746031746031744	0.013126414656763464	IGF1, IGFBP3	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	anaplastic astrocytoma; glioblastoma multiforme	2	3.1746031746031744	0.013126414656763464	TP53, PTEN	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	Carcinoma, Squamous Cell|Head and Neck Neoplasms|Neoplasms, Second Primary|Squamous cell carcinoma	2	3.1746031746031744	0.013126414656763464	TP53, FAS	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
GAD_DISEASE	Diabetes Mellitus|Pancreatic Neoplasms	2	3.1746031746031744	0.013126414656763464	CASP8, FAS	58	3	12971	149.0919540229885	0.9999997549376615	0.1480513136196412	19.146425675781654
BBID	72.IAP_interaction_with_cell_death_pathways	4	6.349206349206349	0.013209669697416548	CASP3, CASP9, CASP8, FAS	15	15	388	6.897777777777778	0.29230355619291803	0.05599454868221743	10.331570781109056
GAD_DISEASE	Precursor Cell Lymphoblastic Leukemia-Lymphoma	4	6.349206349206349	0.013393824002488494	CCND1, CDKN2A, TP53, MDM2	58	113	12971	7.9163869392737265	0.9999998206539275	0.14939886674799108	19.49809604662405
GOTERM_CC_DIRECT	GO:0042567~insulin-like growth factor ternary complex	2	3.1746031746031744	0.013540248668241738	IGF1, IGFBP3	63	4	18224	144.63492063492063	0.8104677274291605	0.10495361121913116	14.526431492489134
GOTERM_MF_DIRECT	GO:0035173~histone kinase activity	2	3.1746031746031744	0.01390832210298071	CCNB1, CDK2	60	4	16881	140.67499999999998	0.8965807074532057	0.13221408334332962	15.589548766598016
BIOCARTA	h_ctcfPathway:CTCF: First Multivalent Nuclear Factor	4	6.349206349206349	0.014057684911355358	CDKN2A, TP53, MDM2, PTEN	35	25	1625	7.428571428571428	0.6590313305597744	0.058024314019262335	13.841255286514853
GOTERM_BP_DIRECT	GO:0051865~protein autoubiquitination	3	4.761904761904762	0.01466414607697854	DDB2, MDM2, RCHY1	63	50	16792	15.992380952380952	0.9999937359397677	0.12463880954556261	20.321366492553917
GOTERM_BP_DIRECT	GO:1902510~regulation of apoptotic DNA fragmentation	2	3.1746031746031744	0.014688648078106093	CDKN2A, APAF1	63	4	16792	133.26984126984127	0.9999938610024035	0.12355161370178847	20.351829260583454
GOTERM_CC_DIRECT	GO:0005813~centrosome	6	9.523809523809524	0.014827648075356437	RFWD2, CCNB1, CCNB2, CHEK1, CDK6, CDK2	63	426	18224	4.074223116476637	0.8383818036886155	0.10765942491833203	15.801994995004575
GOTERM_CC_DIRECT	GO:0031093~platelet alpha granule lumen	3	4.761904761904762	0.015063071203976049	SERPINE1, IGF1, THBS1	63	55	18224	15.778354978354976	0.8430261311288842	0.1031997364983207	16.03336492412749
OMIM_DISEASE	114480~Breast cancer	2	3.1746031746031744	0.01511626583199096	PPM1D, TP53	25	3	4740	126.4	0.6450414718732354	0.6450414718732354	14.503893753727738
INTERPRO	IPR001841:Zinc finger, RING-type	5	7.936507936507936	0.01519605841052087	RFWD2, MDM2, SIAH1, MDM4, RCHY1	61	295	18559	5.156710197277021	0.9054055110350429	0.15501780143087773	16.780734458463755
GAD_DISEASE	Helicobacter Infections|Stomach Neoplasms	3	4.761904761904762	0.015266058919877938	CCND1, TP53, MDM2	58	43	12971	15.602646351242983	0.9999999798914386	0.1669838671667797	21.920388303217553
UP_SEQ_FEATURE	domain:SWIB	2	3.1746031746031744	0.015357647109279794	MDM2, MDM4	63	5	20063	127.38412698412698	0.9728422754904327	0.36285735761873006	18.031034760975515
INTERPRO	IPR003151:PIK-related kinase, FAT	2	3.1746031746031744	0.01606220268908731	ATR, ATM	61	5	18559	121.69836065573772	0.9173929374106624	0.1531604254459057	17.654514564726888
GAD_DISEASE	brain cancer	3	4.761904761904762	0.016643555036522935	TP53, MDM2, PTEN	58	45	12971	14.90919540229885	0.999999995991003	0.17905003040358058	23.65875688674648
BBID	127.Mito-stress	3	4.761904761904762	0.016721628348089275	BID, CASP3, BAX	15	6	388	12.933333333333334	0.354957027877	0.06071285585448227	12.915374715725548
BBID	152.altered_synaptic_signalling-neurodegenerative_disorders	3	4.761904761904762	0.016721628348089275	BAX, TP53, APAF1	15	6	388	12.933333333333334	0.354957027877	0.06071285585448227	12.915374715725548
GAD_DISEASE	Breast Neoplasms|Mammary Neoplasms|melanoma|ovarian neoplasm|Ovarian Neoplasms|Uveal Neoplasms	2	3.1746031746031744	0.017464153271626152	CDKN2A, CDK4	58	4	12971	111.81896551724138	0.9999999984676375	0.18536465789966328	24.677011467775955
GAD_DISEASE	Adenoma|Colonic Polyps|Colorectal Neoplasms|Hyperplasia	2	3.1746031746031744	0.017464153271626152	IGF1, IGFBP3	58	4	12971	111.81896551724138	0.9999999984676375	0.18536465789966328	24.677011467775955
GAD_DISEASE	Bone Neoplasms|osteosarcoma	2	3.1746031746031744	0.017464153271626152	TP53, FAS	58	4	12971	111.81896551724138	0.9999999984676375	0.18536465789966328	24.677011467775955
GAD_DISEASE	Carcinoma, Endometrioid|Endometrial Neoplasms|Microsatellite Instability	2	3.1746031746031744	0.017464153271626152	ATR, PTEN	58	4	12971	111.81896551724138	0.9999999984676375	0.18536465789966328	24.677011467775955
GAD_DISEASE	Breast density	2	3.1746031746031744	0.017464153271626152	IGF1, IGFBP3	58	4	12971	111.81896551724138	0.9999999984676375	0.18536465789966328	24.677011467775955
GOTERM_MF_DIRECT	GO:0004722~protein serine/threonine phosphatase activity	3	4.761904761904762	0.017511806836805498	PPM1D, CYCS, PTEN	60	58	16881	14.552586206896551	0.9428483087792556	0.15494677420391068	19.24731122721982
GAD_DISEASE	Infection|Inflammation|Premature Birth	4	6.349206349206349	0.01751944288656087	SERPINE1, IGF1, FAS, IGFBP3	58	125	12971	7.156413793103448	0.9999999985638254	0.1842218432930327	24.74515854509668
INTERPRO	IPR008271:Serine/threonine-protein kinase, active site	5	7.936507936507936	0.01828344261379901	CHEK1, CDK6, CHEK2, CDK4, CDK2	61	312	18559	4.875735603194619	0.9416740492468577	0.1627283925659767	19.85704118990508
GOTERM_BP_DIRECT	GO:1902749~regulation of cell cycle G2/M phase transition	2	3.1746031746031744	0.018327515353955885	TP53, GTSE1	63	5	16792	106.615873015873	0.9999996945589236	0.1504596835147879	24.757005429602884
GOTERM_BP_DIRECT	GO:0010757~negative regulation of plasminogen activation	2	3.1746031746031744	0.018327515353955885	SERPINE1, THBS1	63	5	16792	106.615873015873	0.9999996945589236	0.1504596835147879	24.757005429602884
UP_SEQ_FEATURE	region of interest:Interaction with HIPK2	2	3.1746031746031744	0.018401212065592868	TP53, TP73	63	6	20063	106.15343915343915	0.986798443591955	0.3817265880376901	21.22711413426589
UP_SEQ_FEATURE	domain:FAT	2	3.1746031746031744	0.018401212065592868	ATR, ATM	63	6	20063	106.15343915343915	0.986798443591955	0.3817265880376901	21.22711413426589
UP_SEQ_FEATURE	domain:FATC	2	3.1746031746031744	0.018401212065592868	ATR, ATM	63	6	20063	106.15343915343915	0.986798443591955	0.3817265880376901	21.22711413426589
GAD_DISEASE	Connective Tissue Diseases|Fetal Diseases|Inflammation|Musculoskeletal Diseases|Pregnancy Complications, Hematologic|Premature Birth|Skin Diseases	4	6.349206349206349	0.01864973034484429	SERPINE1, IGF1, FAS, IGFBP3	58	128	12971	6.988685344827586	0.9999999996186698	0.19323777322541602	26.125682323403776
GAD_DISEASE	Inflammation|Premature Birth	4	6.349206349206349	0.01864973034484429	SERPINE1, IGF1, FAS, IGFBP3	58	128	12971	6.988685344827586	0.9999999996186698	0.19323777322541602	26.125682323403776
GAD_DISEASE	liver cancer	3	4.761904761904762	0.01880530713750743	CCND1, TP53, MDM2	58	48	12971	13.977370689655173	0.9999999996823277	0.19298398808626038	26.31383217690989
GAD_DISEASE	Leukemia, Myeloid, Acute	3	4.761904761904762	0.01880530713750743	TP53, MDM2, FAS	58	48	12971	13.977370689655173	0.9999999996823277	0.19298398808626038	26.31383217690989
KEGG_PATHWAY	hsa04919:Thyroid hormone signaling pathway	5	7.936507936507936	0.018821486032595022	CCND1, CASP9, TSC2, TP53, MDM2	63	114	6910	4.810637705374547	0.8665584389590975	0.06290507839017145	19.201280782692166
BBID	150.caspase_and_NFKB_activation	4	6.349206349206349	0.018899465787297138	BID, CASP3, CASP9, CASP8	15	17	388	6.086274509803922	0.3910925090648092	0.06012756065839009	14.48459659766318
GOTERM_BP_DIRECT	GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process	4	6.349206349206349	0.01895913832672202	CCNB1, MDM2, SIAH1, RCHY1	63	153	16792	6.968357713455752	0.9999998187677721	0.15373202208201198	25.498038456243656
INTERPRO	IPR012346:p53/RUNT-type transcription factor, DNA-binding domain	2	3.1746031746031744	0.019244064704962708	TP53, TP73	61	6	18559	101.4153005464481	0.9498367647577777	0.1614053440411357	20.79273444436156
INTERPRO	IPR003121:SWIB/MDM2 domain	2	3.1746031746031744	0.019244064704962708	MDM2, MDM4	61	6	18559	101.4153005464481	0.9498367647577777	0.1614053440411357	20.79273444436156
INTERPRO	IPR014009:PIK-related kinase	2	3.1746031746031744	0.019244064704962708	ATR, ATM	61	6	18559	101.4153005464481	0.9498367647577777	0.1614053440411357	20.79273444436156
INTERPRO	IPR003152:PIK-related kinase, FATC	2	3.1746031746031744	0.019244064704962708	ATR, ATM	61	6	18559	101.4153005464481	0.9498367647577777	0.1614053440411357	20.79273444436156
GOTERM_MF_DIRECT	GO:0004197~cysteine-type endopeptidase activity	3	4.761904761904762	0.019258096545113925	CASP3, CASP9, CASP8	60	61	16881	13.836885245901641	0.9571583192539225	0.16055434918269662	20.967077221289088
GAD_DISEASE	atherosclerosis	6	9.523809523809524	0.019544236360286314	CDKN2A, SERPINE1, TP53, IGF1, THBS1, IGFBP3	58	355	12971	3.7797960174842156	0.9999999998666292	0.19808783706228827	27.201350612878873
GOTERM_BP_DIRECT	GO:0071407~cellular response to organic cyclic compound	3	4.761904761904762	0.020052727558614127	CCNB1, CASP3, CASP8	63	59	16792	13.552865213882162	0.999999926650603	0.16034676942320325	26.764948625202713
GOTERM_CC_DIRECT	GO:0031265~CD95 death-inducing signaling complex	2	3.1746031746031744	0.020242566695168787	CASP8, FAS	63	6	18224	96.42328042328042	0.9174978651393878	0.12943015180571094	20.97907076981852
GAD_DISEASE	Glaucoma, Open-Angle	3	4.761904761904762	0.020308738396515903	CDKN1A, SERPINE1, TP53	58	50	12971	13.418275862068965	0.9999999999457002	0.20329758350673455	28.109025990836834
GOTERM_MF_DIRECT	GO:0003684~damaged DNA binding	3	4.761904761904762	0.020461391838174376	TP53, DDB2, TP73	60	63	16881	13.397619047619049	0.9648850193791371	0.16160830004636262	22.132473170237354
GOTERM_MF_DIRECT	GO:0070728~leucine binding	2	3.1746031746031744	0.020790994679021017	SESN2, SESN1	60	6	16881	93.78333333333333	0.9667482421714526	0.15648903891331	22.448932641997775
SMART	SM01343:SM01343	2	3.1746031746031744	0.021291536034938986	ATR, ATM	37	6	10057	90.60360360360362	0.49776495580082347	0.15816543556119333	17.005314142313978
GOTERM_BP_DIRECT	GO:0001933~negative regulation of protein phosphorylation	3	4.761904761904762	0.021346846140114128	CCNB1, IGFBP3, PTEN	63	61	16792	13.108508977361435	0.9999999748836332	0.1682370994681387	28.238142621031347
GOTERM_BP_DIRECT	GO:0006950~response to stress	3	4.761904761904762	0.021346846140114128	GADD45G, GADD45B, GADD45A	63	61	16792	13.108508977361435	0.9999999748836332	0.1682370994681387	28.238142621031347
GOTERM_BP_DIRECT	GO:0055114~oxidation-reduction process	7	11.11111111111111	0.021688041866581263	STEAP3, TP53I3, RRM2, CYCS, RRM2B, SESN1, SESN3	63	592	16792	3.1516516516516515	0.9999999810704359	0.16909083736076747	28.621910097334535
GAD_DISEASE	Carcinoma, Hepatocellular|Hepatitis B, Chronic|Liver Neoplasms	2	3.1746031746031744	0.021783158690519284	TP53, MDM2	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	Carcinoma, Papillary|DNA Damage|Neoplasms, Radiation-Induced|thyroid neoplasm|Thyroid Neoplasms	2	3.1746031746031744	0.021783158690519284	TP53, ATM	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	Carcinoma, Renal Cell|Renal Cell Carcinoma	2	3.1746031746031744	0.021783158690519284	CASP8, FAS	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	Adenocarcinoma|Carcinoma, Squamous Cell|Esophageal Neoplasms|Stomach Neoplasms	2	3.1746031746031744	0.021783158690519284	TP53, PTEN	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	Chromosome Aberrations|Chromosome abnormality|Chronic Lymphocytic Leukemia|Leukemia, Lymphocytic, Chronic, B-Cell	2	3.1746031746031744	0.021783158690519284	TP53, ATM	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	Carcinoma, Squamous Cell|Lymphatic Metastasis|Mouth Neoplasms	2	3.1746031746031744	0.021783158690519284	TP53, MDM2	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	Carcinoma, Squamous Cell|Mouth Neoplasms|Neoplasm Metastasis|Squamous cell carcinoma	2	3.1746031746031744	0.021783158690519284	CCND1, TP53	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	Brain Neoplasms|	2	3.1746031746031744	0.021783158690519284	IGF1, IGFBP3	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	body mass; birth weight; height	2	3.1746031746031744	0.021783158690519284	IGF1, IGFBP3	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	non-small cell lung carcinoma	2	3.1746031746031744	0.021783158690519284	CDKN2A, TP53	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	gastritis, chronic atrophic; stomach cancer	2	3.1746031746031744	0.021783158690519284	CDKN1A, TP53	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GAD_DISEASE	prostate carcinoma	2	3.1746031746031744	0.021783158690519284	CASP8, TP53	58	5	12971	89.45517241379311	0.999999999990422	0.21465628507846812	29.82967569480609
GOTERM_BP_DIRECT	GO:0070245~positive regulation of thymocyte apoptotic process	2	3.1746031746031744	0.021953159843191072	BBC3, TP53	63	6	16792	88.84656084656085	0.9999999848057367	0.16938693261092952	28.91878174537955
GAD_DISEASE	Arthritis, Rheumatoid|	4	6.349206349206349	0.02313513428533943	SERPINE1, TP53, MDM2, CDK6	58	139	12971	6.435623914661374	0.9999999999980531	0.22460677274596674	31.373417736269417
GOTERM_BP_DIRECT	GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process	3	4.761904761904762	0.023351458035649794	RFWD2, MDM2, RCHY1	63	64	16792	12.494047619047619	0.9999999952382542	0.17760729936213504	30.46554852321357
KEGG_PATHWAY	hsa05168:Herpes simplex infection	6	9.523809523809524	0.023634170317870674	CASP3, CYCS, CASP8, TP53, FAS, CDK2	63	183	6910	3.5961488420504812	0.9207621629954054	0.07617088721829879	23.538561276815372
GOTERM_BP_DIRECT	GO:0046330~positive regulation of JNK cascade	3	4.761904761904762	0.024036301494083777	GADD45G, GADD45B, GADD45A	63	65	16792	12.3018315018315	0.9999999973041134	0.1807028755855834	31.211572832763867
GOTERM_BP_DIRECT	GO:0016032~viral process	5	7.936507936507936	0.024521078074164693	BAX, TSC2, TP53, MDM2, TP73	63	299	16792	4.457185326750544	0.9999999981981921	0.18236949744736175	31.73512636069663
INTERPRO	IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site	2	3.1746031746031744	0.0255774646558823	BID, BAX	61	8	18559	76.06147540983606	0.9815036017083231	0.19882559790257004	26.715396867727126
GOTERM_BP_DIRECT	GO:0001666~response to hypoxia	4	6.349206349206349	0.025703249992144007	CASP3, APAF1, THBS1, ATM	63	172	16792	6.1985972683647095	0.9999999993260823	0.18867636541514787	32.99628082759863
GAD_DISEASE	Skin Neoplasms	2	3.1746031746031744	0.02608351037645532	TP53, MDM2	58	6	12971	74.54597701149424	0.9999999999999402	0.24764856990080175	34.630216611144945
GAD_DISEASE	colon cancer rectal cancer	2	3.1746031746031744	0.02608351037645532	IGF1, IGFBP3	58	6	12971	74.54597701149424	0.9999999999999402	0.24764856990080175	34.630216611144945
GAD_DISEASE	Cervical Intraepithelial Neoplasia|Cervical Neoplasm|Uterine Cervical Neoplasms	2	3.1746031746031744	0.02608351037645532	TP53, FAS	58	6	12971	74.54597701149424	0.9999999999999402	0.24764856990080175	34.630216611144945
GAD_DISEASE	prostate cancer   | breast cancer   	2	3.1746031746031744	0.02608351037645532	IGF1, IGFBP3	58	6	12971	74.54597701149424	0.9999999999999402	0.24764856990080175	34.630216611144945
GAD_DISEASE	upper aerodigestive tract cancer	2	3.1746031746031744	0.02608351037645532	CCND1, CHEK2	58	6	12971	74.54597701149424	0.9999999999999402	0.24764856990080175	34.630216611144945
GAD_DISEASE	esophageal cancer gastric cardiac cancer	2	3.1746031746031744	0.02608351037645532	CDKN1A, TP73	58	6	12971	74.54597701149424	0.9999999999999402	0.24764856990080175	34.630216611144945
GAD_DISEASE	Brain Neoplasms	2	3.1746031746031744	0.02608351037645532	CDKN1A, TP53	58	6	12971	74.54597701149424	0.9999999999999402	0.24764856990080175	34.630216611144945
GOTERM_BP_DIRECT	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	3	4.761904761904762	0.026857056406872012	MDM2, SFN, THBS1	63	69	16792	11.588681849551415	0.9999999997422175	0.19463513432676627	34.206140421164534
GOTERM_MF_DIRECT	GO:0061630~ubiquitin protein ligase activity	4	6.349206349206349	0.027645518127250954	RFWD2, MDM2, SIAH1, MDM4	60	187	16881	6.018181818181818	0.9893441402926065	0.1944812710327607	28.768541011379124
GOTERM_BP_DIRECT	GO:0051260~protein homooligomerization	4	6.349206349206349	0.027665966389031238	BID, BAX, APAF1, FAS	63	177	16792	6.0234956506142945	0.9999999998686712	0.1982079448123557	35.04213503898357
GOTERM_MF_DIRECT	GO:0004842~ubiquitin-protein transferase activity	5	7.936507936507936	0.027873570592668293	RFWD2, DDB2, MDM2, SIAH1, RCHY1	60	329	16881	4.2758358662613976	0.9897414592342183	0.18792750807975012	28.97043341844099
INTERPRO	IPR009078:Ferritin-like superfamily	2	3.1746031746031744	0.028729065760528784	RRM2, RRM2B	61	9	18559	67.61020036429872	0.9887689480023516	0.21043016259208647	29.508746500344618
GOTERM_MF_DIRECT	GO:0019899~enzyme binding	5	7.936507936507936	0.028963877334155442	CCND1, TP53, MDM2, MDM4, PTEN	60	333	16881	4.224474474474475	0.9914467230413908	0.18699593154200667	29.92843600922408
GOTERM_BP_DIRECT	GO:0032471~negative regulation of endoplasmic reticulum calcium ion concentration	2	3.1746031746031744	0.029164969354396716	BBC3, BAX	63	8	16792	66.63492063492063	0.9999999999624205	0.2061121756514147	36.56513503573001
GOTERM_BP_DIRECT	GO:0046626~regulation of insulin receptor signaling pathway	2	3.1746031746031744	0.029164969354396716	TSC2, SESN3	63	8	16792	66.63492063492063	0.9999999999624205	0.2061121756514147	36.56513503573001
GOTERM_BP_DIRECT	GO:0033129~positive regulation of histone phosphorylation	2	3.1746031746031744	0.029164969354396716	CCNB1, ATM	63	8	16792	66.63492063492063	0.9999999999624205	0.2061121756514147	36.56513503573001
GOTERM_BP_DIRECT	GO:1903896~positive regulation of IRE1-mediated unfolded protein response	2	3.1746031746031744	0.029164969354396716	BBC3, BAX	63	8	16792	66.63492063492063	0.9999999999624205	0.2061121756514147	36.56513503573001
GAD_DISEASE	Adenocarcinoma|Esophageal Neoplasms|Esophagitis|Metaplasia|Oesophageal neoplasm	2	3.1746031746031744	0.03036528746106234	IGF1, IGFBP3	58	7	12971	63.89655172413793	0.9999999999999997	0.2802964418185475	39.102673184261505
GAD_DISEASE	Acromegaly	2	3.1746031746031744	0.03036528746106234	IGF1, IGFBP3	58	7	12971	63.89655172413793	0.9999999999999997	0.2802964418185475	39.102673184261505
GAD_DISEASE	Brain Neoplasms|Glioma|Meningeal Neoplasms|Meningioma	2	3.1746031746031744	0.03036528746106234	TP53, ATM	58	7	12971	63.89655172413793	0.9999999999999997	0.2802964418185475	39.102673184261505
GAD_DISEASE	HELLP Syndrome	2	3.1746031746031744	0.03036528746106234	SERPINE1, FAS	58	7	12971	63.89655172413793	0.9999999999999997	0.2802964418185475	39.102673184261505
GOTERM_BP_DIRECT	GO:0042127~regulation of cell proliferation	4	6.349206349206349	0.03096872727516387	BID, TNFRSF10B, CHEK1, FAS	63	185	16792	5.763020163020163	0.9999999999916833	0.21571173903867547	38.35350523713048
GOTERM_BP_DIRECT	GO:0007623~circadian rhythm	3	4.761904761904762	0.031324983172701444	SERPINE1, FAS, CDK4	63	75	16792	10.661587301587302	0.9999999999938278	0.21612030043070052	38.701099882250624
GOTERM_BP_DIRECT	GO:0034976~response to endoplasmic reticulum stress	3	4.761904761904762	0.031324983172701444	TNFRSF10B, BBC3, THBS1	63	75	16792	10.661587301587302	0.9999999999938278	0.21612030043070052	38.701099882250624
GAD_DISEASE	Lupus Erythematosus, Systemic|Systemic lupus erythematosus	4	6.349206349206349	0.031632585926279544	CDKN1A, TP53, FAS, PTEN	58	157	12971	5.6977816824072045	0.9999999999999999	0.2880307892715104	40.37033055251161
GOTERM_BP_DIRECT	GO:0000075~cell cycle checkpoint	2	3.1746031746031744	0.03275122840419688	CCNE2, CCNG2	63	9	16792	59.2310405643739	0.9999999999981316	0.22305984896478248	40.07440075775398
GOTERM_BP_DIRECT	GO:0010389~regulation of G2/M transition of mitotic cell cycle	2	3.1746031746031744	0.03275122840419688	CCNB3, CDKN2A	63	9	16792	59.2310405643739	0.9999999999981316	0.22305984896478248	40.07440075775398
GOTERM_BP_DIRECT	GO:0003014~renal system process	2	3.1746031746031744	0.03275122840419688	FAS, RRM2B	63	9	16792	59.2310405643739	0.9999999999981316	0.22305984896478248	40.07440075775398
GOTERM_MF_DIRECT	GO:0016491~oxidoreductase activity	4	6.349206349206349	0.032804312516741506	TP53I3, RRM2, RRM2B, SESN3	60	200	16881	5.627	0.9954988350135071	0.20159752942011633	33.20923234309285
GAD_DISEASE	restenosis	3	4.761904761904762	0.03401211151252259	SERPINE1, TP53, MDM2	58	66	12971	10.165360501567397	1.0	0.3039947480703704	42.683944404829276
KEGG_PATHWAY	hsa04120:Ubiquitin mediated proteolysis	5	7.936507936507936	0.03404840976297904	RFWD2, DDB2, MDM2, SIAH1, RCHY1	63	137	6910	4.003012397172981	0.9745745674159885	0.10530543631430545	32.2071610503272
GAD_DISEASE	gastric carcinoma	2	3.1746031746031744	0.034628568749736105	CCND1, TP53	58	8	12971	55.90948275862069	1.0	0.30632964998377743	43.26944494903741
GAD_DISEASE	Growth Disorders	2	3.1746031746031744	0.034628568749736105	IGF1, IGFBP3	58	8	12971	55.90948275862069	1.0	0.30632964998377743	43.26944494903741
KEGG_PATHWAY	hsa04310:Wnt signaling pathway	5	7.936507936507936	0.03483546461631742	CCND1, CCND3, CCND2, TP53, SIAH1	63	138	6910	3.974005060961583	0.9766791869694615	0.10465077632712183	32.82440682790258
GOTERM_BP_DIRECT	GO:0043410~positive regulation of MAPK cascade	3	4.761904761904762	0.036064535060646725	IGF1, FAS, IGFBP3	63	81	16792	9.871840094062316	0.9999999999998844	0.24105205601661928	43.1544731190626
GOTERM_BP_DIRECT	GO:0051918~negative regulation of fibrinolysis	2	3.1746031746031744	0.036324452730065494	SERPINE1, THBS1	63	10	16792	53.3079365079365	0.9999999999999071	0.24065428547710743	43.38972350842759
GOTERM_BP_DIRECT	GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling	2	3.1746031746031744	0.036324452730065494	TSC2, PTEN	63	10	16792	53.3079365079365	0.9999999999999071	0.24065428547710743	43.38972350842759
GOTERM_BP_DIRECT	GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	2	3.1746031746031744	0.036324452730065494	BID, BAX	63	10	16792	53.3079365079365	0.9999999999999071	0.24065428547710743	43.38972350842759
GOTERM_BP_DIRECT	GO:0016572~histone phosphorylation	2	3.1746031746031744	0.036324452730065494	ATM, CDK2	63	10	16792	53.3079365079365	0.9999999999999071	0.24065428547710743	43.38972350842759
GOTERM_BP_DIRECT	GO:0060044~negative regulation of cardiac muscle cell proliferation	2	3.1746031746031744	0.036324452730065494	PTEN, TP73	63	10	16792	53.3079365079365	0.9999999999999071	0.24065428547710743	43.38972350842759
GOTERM_BP_DIRECT	GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	2	3.1746031746031744	0.036324452730065494	BBC3, PMAIP1	63	10	16792	53.3079365079365	0.9999999999999071	0.24065428547710743	43.38972350842759
GOTERM_BP_DIRECT	GO:0046902~regulation of mitochondrial membrane permeability	2	3.1746031746031744	0.036324452730065494	TP53, PMAIP1	63	10	16792	53.3079365079365	0.9999999999999071	0.24065428547710743	43.38972350842759
GAD_DISEASE_CLASS	NEUROLOGICAL	20	31.746031746031743	0.03637798942036488	TP53, IGF1, CCNG2, PTEN, ATM, TP73, SESN3, RFWD2, CCNE1, CDKN2A, CCND3, CCND2, BAX, GADD45G, CASP8, SERPINE1, SIAH1, FAS, MDM4, IGFBP3	58	2890	12971	1.5476673427991887	0.48675963537099665	0.0588355213378805	23.902102673108484
GAD_DISEASE	Arthritis, Rheumatoid	4	6.349206349206349	0.036417045744102025	SERPINE1, CDK6, RCHY1, CCNG2	58	166	12971	5.388865808059826	1.0	0.31720870494391895	44.936526258708064
KEGG_PATHWAY	hsa04510:Focal adhesion	6	9.523809523809524	0.03679943312236082	CCND1, CCND3, CCND2, IGF1, THBS1, PTEN	63	206	6910	3.1946370781322235	0.9812079859609864	0.1073423067709881	34.342384835813775
GOTERM_MF_DIRECT	GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity	2	3.1746031746031744	0.03779173810981632	CDKN1A, CDKN2A	60	11	16881	51.154545454545456	0.9980519898315755	0.22091714196576884	37.25956125184434
SMART	SM00220:S_TKc	5	7.936507936507936	0.038278507374095334	CHEK1, CDK6, CHEK2, CDK4, CDK2	37	359	10057	3.7856658887299557	0.7132005609024772	0.2210390986535382	28.682976705967466
GAD_DISEASE	Retinal Neoplasms|Retinoblastoma	2	3.1746031746031744	0.03887343271314725	MDM2, PTEN	58	9	12971	49.69731800766284	1.0	0.33249677543718403	47.15140369208878
GAD_DISEASE	Multiple Endocrine Neoplasia Type 1	2	3.1746031746031744	0.03887343271314725	CDKN1A, CDKN2A	58	9	12971	49.69731800766284	1.0	0.33249677543718403	47.15140369208878
GAD_DISEASE	Osteosarcoma	2	3.1746031746031744	0.03887343271314725	TP53, MDM2	58	9	12971	49.69731800766284	1.0	0.33249677543718403	47.15140369208878
GOTERM_MF_DIRECT	GO:0008233~peptidase activity	3	4.761904761904762	0.03952621734442516	CASP3, CASP9, CASP8	60	90	16881	9.378333333333334	0.9985457020617492	0.2221940086044848	38.614471108562796
OMIM_DISEASE	114480~Breast cancer, susceptibility to	2	3.1746031746031744	0.03982461455336569	CHEK2, ATM	25	8	4740	47.4	0.9369277021881423	0.7488580126465154	34.16944815092263
GOTERM_BP_DIRECT	GO:0097202~activation of cysteine-type endopeptidase activity	2	3.1746031746031744	0.03988468893040198	CASP8, PERP	63	11	16792	48.46176046176046	0.9999999999999953	0.25924393523351874	46.52181110060185
GOTERM_CC_DIRECT	GO:0031932~TORC2 complex	2	3.1746031746031744	0.040081849049532874	SESN2, SESN3	63	12	18224	48.21164021164021	0.9931989986817746	0.23100257189220308	37.561778426441386
GOTERM_BP_DIRECT	GO:0001822~kidney development	3	4.761904761904762	0.04021177831599368	BAX, RRM2B, TP73	63	86	16792	9.297895902547063	0.9999999999999964	0.2590854389831514	46.80128695872956
GAD_DISEASE	preeclampsia	3	4.761904761904762	0.04291743207593173	SERPINE1, IGF1, FAS	58	75	12971	8.94551724137931	1.0	0.35806842808199013	50.61673269485889
GOTERM_BP_DIRECT	GO:0007275~multicellular organism development	6	9.523809523809524	0.04299341022104286	TNFRSF10B, GADD45G, TP53, SIAH1, ATR, GADD45B	63	521	16792	3.0695548852938486	0.9999999999999997	0.2725491890989694	49.1234233957705
GAD_DISEASE	neuropathy	2	3.1746031746031744	0.043099957505337474	TP53, FAS	58	10	12971	44.727586206896554	1.0	0.356819330451038	50.76799755975061
GAD_DISEASE	Glaucoma, Open-Angle|Low Tension Glaucoma|Ocular Hypertension	2	3.1746031746031744	0.043099957505337474	CDKN1A, TP53	58	10	12971	44.727586206896554	1.0	0.356819330451038	50.76799755975061
UP_KEYWORDS	Acetylation	17	26.984126984126984	0.04382026797759041	BID, CYCS, TP53, CDK6, CDK4, SESN2, PTEN, CDK2, ATM, CCNB1, EI24, TP53I3, CDKN1A, CASP3, CDKN2A, BAX, CASP8	63	3424	20581	1.621963543984572	0.9953789139569112	0.22589952142364556	40.21296266598713
GAD_DISEASE	pregnancy loss	3	4.761904761904762	0.04500299833398807	SERPINE1, TP53, MDM2	58	77	12971	8.713166144200628	1.0	0.3670064969726906	52.319439640041054
UP_SEQ_FEATURE	metal ion-binding site:Iron 1	2	3.1746031746031744	0.04538006050366597	RRM2, RRM2B	63	15	20063	42.46137566137566	0.9999800240784147	0.6611162982155536	44.93398292886055
UP_SEQ_FEATURE	metal ion-binding site:Iron 2	2	3.1746031746031744	0.04538006050366597	RRM2, RRM2B	63	15	20063	42.46137566137566	0.9999800240784147	0.6611162982155536	44.93398292886055
GOTERM_BP_DIRECT	GO:0097284~hepatocyte apoptotic process	2	3.1746031746031744	0.04696638255466278	BID, FAS	63	13	16792	41.006105006105	1.0	0.29195659524823225	52.276191607033404
GOTERM_BP_DIRECT	GO:0046685~response to arsenic-containing substance	2	3.1746031746031744	0.04696638255466278	CDKN1A, PTEN	63	13	16792	41.006105006105	1.0	0.29195659524823225	52.276191607033404
GOTERM_BP_DIRECT	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	2	3.1746031746031744	0.04696638255466278	IGF1, IGFBP3	63	13	16792	41.006105006105	1.0	0.29195659524823225	52.276191607033404
GOTERM_BP_DIRECT	GO:0071850~mitotic cell cycle arrest	2	3.1746031746031744	0.04696638255466278	CDKN1A, GADD45A	63	13	16792	41.006105006105	1.0	0.29195659524823225	52.276191607033404
GAD_DISEASE	Neoplasms, Prostatic|Prostatic Neoplasms	2	3.1746031746031744	0.04730822094333685	TNFRSF10B, FAS	58	11	12971	40.66144200626959	1.0	0.37947073832619904	54.13734804550625
GAD_DISEASE	Rectal Neoplasms	2	3.1746031746031744	0.04730822094333685	TP53, TP73	58	11	12971	40.66144200626959	1.0	0.37947073832619904	54.13734804550625
GOTERM_MF_DIRECT	GO:0002020~protease binding	3	4.761904761904762	0.04864671210640364	CASP3, SERPINE1, TP53	60	101	16881	8.356930693069307	0.9996899902174927	0.2586028014251135	45.30781517054627
GOTERM_BP_DIRECT	GO:1902043~positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	2	3.1746031746031744	0.05048793236669973	PMAIP1, THBS1	63	14	16792	38.07709750566893	1.0	0.30826828645172544	54.917075515624525
GOTERM_BP_DIRECT	GO:0042176~regulation of protein catabolic process	2	3.1746031746031744	0.05048793236669973	MDM2, CHEK2	63	14	16792	38.07709750566893	1.0	0.30826828645172544	54.917075515624525
GOTERM_BP_DIRECT	GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	2	3.1746031746031744	0.05048793236669973	BAX, FAS	63	14	16792	38.07709750566893	1.0	0.30826828645172544	54.917075515624525
GOTERM_BP_DIRECT	GO:0030194~positive regulation of blood coagulation	2	3.1746031746031744	0.05048793236669973	SERPINE1, THBS1	63	14	16792	38.07709750566893	1.0	0.30826828645172544	54.917075515624525
GOTERM_BP_DIRECT	GO:0030889~negative regulation of B cell proliferation	2	3.1746031746031744	0.05048793236669973	CDKN2A, ATM	63	14	16792	38.07709750566893	1.0	0.30826828645172544	54.917075515624525
GOTERM_BP_DIRECT	GO:0014912~negative regulation of smooth muscle cell migration	2	3.1746031746031744	0.05048793236669973	SERPINE1, IGFBP3	63	14	16792	38.07709750566893	1.0	0.30826828645172544	54.917075515624525
GOTERM_BP_DIRECT	GO:0048009~insulin-like growth factor receptor signaling pathway	2	3.1746031746031744	0.05048793236669973	TSC2, IGF1	63	14	16792	38.07709750566893	1.0	0.30826828645172544	54.917075515624525
INTERPRO	IPR018936:Phosphatidylinositol 3/4-kinase, conserved site	2	3.1746031746031744	0.05051135111969787	ATR, ATM	61	16	18559	38.03073770491803	0.9996584725018788	0.32907915724004255	46.300880730210935
GAD_DISEASE	Thyroid Diseases	2	3.1746031746031744	0.05149830052647814	IGF1, IGFBP3	58	12	12971	37.27298850574712	1.0	0.4031987597871649	57.27634040992283
GAD_DISEASE	mamographic density	2	3.1746031746031744	0.05149830052647814	IGF1, IGFBP3	58	12	12971	37.27298850574712	1.0	0.4031987597871649	57.27634040992283
GOTERM_CC_DIRECT	GO:0043234~protein complex	5	7.936507936507936	0.0515386319067213	CDKN1A, CDKN2A, TP53, DDB2, MDM2	63	412	18224	3.5105563260903065	0.9984282015869427	0.27586449424079884	45.62342589953888
BIOCARTA	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis	3	4.761904761904762	0.052742928082820356	CDKN2A, TP53, MDM2	35	18	1625	7.738095238095239	0.983723647910175	0.1948599596344892	43.45800751935903
UP_KEYWORDS	Ubl conjugation pathway	6	9.523809523809524	0.053756168871206676	RFWD2, CDKN2A, DDB2, MDM2, SIAH1, RCHY1	63	680	20581	2.8824929971988795	0.9986806277505822	0.26021144775425153	46.968806479855644
GOTERM_BP_DIRECT	GO:0001953~negative regulation of cell-matrix adhesion	2	3.1746031746031744	0.05399667883491015	CDKN2A, THBS1	63	15	16792	35.53862433862434	1.0	0.3239312632119624	57.41196606884231
UP_SEQ_FEATURE	zinc finger region:RanBP2-type	2	3.1746031746031744	0.054209847095011685	MDM2, MDM4	63	18	20063	35.38447971781305	0.9999977081530361	0.6928930807956901	51.13058969485438
UP_SEQ_FEATURE	domain:PI3K/PI4K	2	3.1746031746031744	0.054209847095011685	ATR, ATM	63	18	20063	35.38447971781305	0.9999977081530361	0.6928930807956901	51.13058969485438
GOTERM_MF_DIRECT	GO:0019789~SUMO transferase activity	2	3.1746031746031744	0.05450223676708675	CDKN2A, MDM2	60	16	16881	35.168749999999996	0.9998859745132543	0.27693283471359853	49.244864330831085
GAD_DISEASE	Alzheimer's disease   	9	14.285714285714285	0.0546234752326783	CDKN2A, CCND3, SERPINE1, TP53, IGF1, FAS, IGFBP3, PTEN, TP73	58	950	12971	2.1186751361161527	1.0	0.4194519133291361	59.485127901025535
GOTERM_BP_DIRECT	GO:0002576~platelet degranulation	3	4.761904761904762	0.05555073599672544	SERPINE1, IGF1, THBS1	63	103	16792	7.7632917244567725	1.0	0.3293986786683405	58.475198676412646
GAD_DISEASE	Cervical Neoplasm|Papillomavirus Infections|Uterine Cervical Neoplasms	2	3.1746031746031744	0.055670273430979834	TP53, MDM2	58	13	12971	34.40583554376658	1.0	0.42298494280244103	60.200707923952
GOTERM_CC_DIRECT	GO:0005657~replication fork	2	3.1746031746031744	0.05631222783783271	TP53, CHEK1	63	17	18224	34.03174603174603	0.999150710057799	0.28589089485197416	48.69239669668796
GOTERM_BP_DIRECT	GO:0045471~response to ethanol	3	4.761904761904762	0.057472335451457905	CCND1, CASP8, PTEN	63	105	16792	7.615419501133786	1.0	0.3365374530287861	59.75557799629877
GOTERM_BP_DIRECT	GO:0051895~negative regulation of focal adhesion assembly	2	3.1746031746031744	0.05749266773865128	THBS1, PTEN	63	16	16792	33.317460317460316	1.0	0.33432529915945797	59.76892606168922
GOTERM_BP_DIRECT	GO:2000045~regulation of G1/S transition of mitotic cell cycle	2	3.1746031746031744	0.05749266773865128	BID, CCND1	63	16	16792	33.317460317460316	1.0	0.33432529915945797	59.76892606168922
GOTERM_MF_DIRECT	GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process	2	3.1746031746031744	0.05780993721358632	CASP3, APAF1	60	17	16881	33.1	0.9999353691077862	0.2829781025040101	51.35220052802194
INTERPRO	IPR013083:Zinc finger, RING/FYVE/PHD-type	5	7.936507936507936	0.05866424420418532	RFWD2, MDM2, SIAH1, MDM4, RCHY1	61	453	18559	3.3581225346505987	0.9999094973044712	0.35811079479964036	51.5783652079121
SMART	SM00146:PI3Kc	2	3.1746031746031744	0.05918705874928665	ATR, ATM	37	17	10057	31.977742448330684	0.8580599201381778	0.27775561492130096	41.045539392468115
GOTERM_BP_DIRECT	GO:0000187~activation of MAPK activity	3	4.761904761904762	0.05941700722343507	IGF1, THBS1, TP73	63	107	16792	7.473075211392969	1.0	0.3412842745413315	61.01367953556078
INTERPRO	IPR000403:Phosphatidylinositol 3-/4-kinase, catalytic domain	2	3.1746031746031744	0.059698899019586645	ATR, ATM	61	19	18559	32.02588438308887	0.9999235971655178	0.35006696451086605	52.21297151228086
GAD_DISEASE	muscle testing	2	3.1746031746031744	0.05982421651010345	IGF1, IGFBP3	58	14	12971	31.948275862068964	1.0	0.44418207991145386	62.92511038210882
UP_SEQ_FEATURE	domain:Protein kinase	5	7.936507936507936	0.06025887379926103	CHEK1, CDK6, CHEK2, CDK4, CDK2	63	478	20063	3.331174868831772	0.9999994860529324	0.7008356316921609	54.9973177625442
GOTERM_BP_DIRECT	GO:0021542~dentate gyrus development	2	3.1746031746031744	0.060975944718032866	CDK6, PTEN	63	17	16792	31.357609710550882	1.0	0.34635769682026063	61.99557346034415
GOTERM_BP_DIRECT	GO:0055093~response to hyperoxia	2	3.1746031746031744	0.060975944718032866	CDKN1A, CDK4	63	17	16792	31.357609710550882	1.0	0.34635769682026063	61.99557346034415
UP_SEQ_FEATURE	compositionally biased region:Asp/Glu-rich (acidic)	3	4.761904761904762	0.0637394248509075	MDM2, MDM4, TP73	63	133	20063	7.183315431435732	0.9999997835091635	0.6928563779752829	57.09226495020809
GOTERM_BP_DIRECT	GO:0007067~mitotic nuclear division	4	6.349206349206349	0.0637638960341477	CCNB2, CCNG1, CCNG2, CDK2	63	248	16792	4.2990271377368146	1.0	0.35699976361402785	63.694149733655095
GAD_DISEASE	Testicular Neoplasms	2	3.1746031746031744	0.06396020629672286	IGF1, IGFBP3	58	15	12971	29.8183908045977	1.0	0.46427364281121275	65.46320727170642
GAD_DISEASE	Infertility, Female	2	3.1746031746031744	0.06396020629672286	SERPINE1, TP53	58	15	12971	29.8183908045977	1.0	0.46427364281121275	65.46320727170642
GOTERM_BP_DIRECT	GO:0051412~response to corticosterone	2	3.1746031746031744	0.06444655523388293	CDKN1A, CCND1	63	18	16792	29.61552028218695	1.0	0.3577895804960528	64.09910589320295
GOTERM_BP_DIRECT	GO:0010039~response to iron ion	2	3.1746031746031744	0.06444655523388293	CCND1, MDM2	63	18	16792	29.61552028218695	1.0	0.3577895804960528	64.09910589320295
GOTERM_BP_DIRECT	GO:0010971~positive regulation of G2/M transition of mitotic cell cycle	2	3.1746031746031744	0.06444655523388293	CCND1, CDK4	63	18	16792	29.61552028218695	1.0	0.3577895804960528	64.09910589320295
GOTERM_BP_DIRECT	GO:0030220~platelet formation	2	3.1746031746031744	0.06790454460084232	CASP3, CASP9	63	19	16792	28.056808688387633	1.0	0.3710194602058612	66.08632384078756
GOTERM_BP_DIRECT	GO:0045862~positive regulation of proteolysis	2	3.1746031746031744	0.06790454460084232	CASP8, PERP	63	19	16792	28.056808688387633	1.0	0.3710194602058612	66.08632384078756
GAD_DISEASE	Adenocarcinoma|pancreatic neoplasm|Pancreatic Neoplasms	2	3.1746031746031744	0.06807831900557831	IGF1, IGFBP3	58	16	12971	27.954741379310345	1.0	0.48333137696991324	67.82772595951381
GAD_DISEASE	Chronic Lymphocytic Leukemia|Leukemia, Lymphocytic, Chronic, B-Cell	2	3.1746031746031744	0.06807831900557831	TP53, MDM2	58	16	12971	27.954741379310345	1.0	0.48333137696991324	67.82772595951381
GOTERM_MF_DIRECT	GO:0016874~ligase activity	4	6.349206349206349	0.06842934719901701	RFWD2, MDM2, SIAH1, RCHY1	60	270	16881	4.1681481481481475	0.9999896971029025	0.31802993451722295	57.58730939359433
GOTERM_BP_DIRECT	GO:0016925~protein sumoylation	3	4.761904761904762	0.06947150384046896	CDKN2A, TP53, MDM2	63	117	16792	6.834350834350834	1.0	0.37557252683297937	66.95252577359395
GOTERM_BP_DIRECT	GO:0044267~cellular protein metabolic process	3	4.761904761904762	0.07050606267085117	IGF1, SIAH1, IGFBP3	63	118	16792	6.776432606941081	1.0	0.3777230843708814	67.5130364535057
GOTERM_CC_DIRECT	GO:0005730~nucleolus	7	11.11111111111111	0.07052530603193652	CDKN1A, CDKN2A, CCND2, ZMAT3, TP53, MDM2, CDK4	63	857	18224	2.36276416439777	0.9998666529072341	0.33340371539738656	56.917793829664184
GOTERM_BP_DIRECT	GO:0042326~negative regulation of phosphorylation	2	3.1746031746031744	0.07134995795759205	CDKN1A, CDKN2A	63	20	16792	26.65396825396825	1.0	0.379017051137822	67.96365251037213
UP_SEQ_FEATURE	repeat:TNFR-Cys 3	2	3.1746031746031744	0.07162904155721134	TNFRSF10B, FAS	63	24	20063	26.538359788359788	0.9999999698615938	0.7097352446912704	61.51241621677188
GAD_DISEASE	colorectal adenomas	2	3.1746031746031744	0.07217863052979434	BAX, TP53	58	17	12971	26.310344827586206	1.0	0.5014215415789487	70.03052523205437
INTERPRO	IPR000719:Protein kinase, catalytic domain	5	7.936507936507936	0.07244964435276877	CHEK1, CDK6, CHEK2, CDK4, CDK2	61	487	18559	3.1236745548187295	0.9999906680065191	0.39562953039306126	59.43230709181564
GAD_DISEASE	Type 2 diabetes	5	7.936507936507936	0.07320188244037532	CDKN2A, SERPINE1, IGF1, FAS, IGFBP3	58	360	12971	3.1060823754789273	1.0	0.5037105101820469	70.55775191324541
KEGG_PATHWAY	hsa04114:Oocyte meiosis	4	6.349206349206349	0.07399326076286997	CCNE2, CCNE1, IGF1, CDK2	63	109	6910	4.025047327799621	0.9997108656954767	0.20256147736242536	57.79375688384876
UP_KEYWORDS	Iron	4	6.349206349206349	0.0742018484057711	STEAP3, RRM2, CYCS, RRM2B	63	324	20581	4.033117773858514	0.999904069408424	0.3311904226147854	58.73043247881369
GOTERM_BP_DIRECT	GO:0006921~cellular component disassembly involved in execution phase of apoptosis	2	3.1746031746031744	0.0747828402946707	CASP3, CASP8	63	21	16792	25.38473167044595	1.0	0.39125139224589023	69.73716253928694
BIOCARTA	h_ceramidePathway:Ceramide Signaling Pathway	3	4.761904761904762	0.07561585201682154	BAX, CYCS, CASP8	35	22	1625	6.331168831168831	0.997460260435191	0.2582809058728115	56.28147136406677
UP_SEQ_FEATURE	splice variant	31	49.2063492063492	0.0758633494718411	STEAP3, BID, SFN, RRM2B, CHEK2, SESN1, SESN3, CCNE2, CCNE1, TP53I3, CDKN2A, CASP9, CASP8, FAS, RCHY1, TP53, ATR, ATM, TP73, RFWD2, CCNB3, TNFRSF10B, BBC3, SERPINB5, BAX, TSC2, DDB2, MDM2, SIAH1, MDM4, APAF1	63	7760	20063	1.2721997218131238	0.9999999896119678	0.7063913232494609	63.70766168115194
GAD_DISEASE	thrombocytopenia	2	3.1746031746031744	0.07626121645498458	CYCS, FAS	58	18	12971	24.84865900383142	1.0	0.5158041572544922	72.08265451812761
GOTERM_MF_DIRECT	GO:0008134~transcription factor binding	4	6.349206349206349	0.07704841604611774	CCND1, CDKN2A, TP53, TP73	60	284	16881	3.962676056338028	0.9999977144803757	0.3422940470209681	62.09926986456908
UP_SEQ_FEATURE	repeat:TNFR-Cys 1	2	3.1746031746031744	0.07736499528881581	TNFRSF10B, FAS	63	26	20063	24.496947496947495	0.9999999928883045	0.6904375166496555	64.45802268914017
UP_SEQ_FEATURE	repeat:TNFR-Cys 2	2	3.1746031746031744	0.07736499528881581	TNFRSF10B, FAS	63	26	20063	24.496947496947495	0.9999999928883045	0.6904375166496555	64.45802268914017
KEGG_PATHWAY	hsa04010:MAPK signaling pathway	6	9.523809523809524	0.07770611355212045	CASP3, GADD45G, TP53, FAS, GADD45B, GADD45A	63	255	6910	2.5807656395891687	0.9998111360946442	0.20684991071796244	59.65422475072341
UP_KEYWORDS	Thiol protease	3	4.761904761904762	0.07776245596680013	CASP3, CASP9, CASP8	63	153	20581	6.405539993775288	0.9999395862505587	0.3328645920822386	60.51618174705
INTERPRO	IPR001876:Zinc finger, RanBP2-type	2	3.1746031746031744	0.07781251093399758	MDM2, MDM4	61	25	18559	24.339672131147545	0.9999961791427825	0.40535646665010716	62.15825826761049
INTERPRO	IPR001368:TNFR/NGFR cysteine-rich region	2	3.1746031746031744	0.07781251093399758	TNFRSF10B, FAS	61	25	18559	24.339672131147545	0.9999961791427825	0.40535646665010716	62.15825826761049
GOTERM_BP_DIRECT	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	2	3.1746031746031744	0.078203236449074	CDKN1A, CDKN2A	63	22	16792	24.23088023088023	1.0	0.403059968347415	71.41258953845772
GOTERM_BP_DIRECT	GO:0006470~protein dephosphorylation	3	4.761904761904762	0.07896151022048507	PPM1D, CYCS, PTEN	63	126	16792	6.346182917611488	1.0	0.40376046561002776	71.77207980779194
SMART	SM00208:TNFR	2	3.1746031746031744	0.07925203346133639	TNFRSF10B, FAS	37	23	10057	23.635722679200942	0.9287959676884169	0.31439798694696397	51.0864021445937
GOTERM_MF_DIRECT	GO:0005031~tumor necrosis factor-activated receptor activity	2	3.1746031746031744	0.08064745388484286	TNFRSF10B, FAS	60	24	16881	23.445833333333333	0.9999987863387833	0.3466768519370865	63.84944144990992
GOTERM_BP_DIRECT	GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle	2	3.1746031746031744	0.08161119109199473	CCNE1, RRM2	63	23	16792	23.17736369910283	1.0	0.41204679804377253	72.99535255734719
GOTERM_BP_DIRECT	GO:0051439~regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	2	3.1746031746031744	0.08161119109199473	CCNB1, CDK2	63	23	16792	23.17736369910283	1.0	0.41204679804377253	72.99535255734719
GOTERM_BP_DIRECT	GO:0090398~cellular senescence	2	3.1746031746031744	0.08161119109199473	CDKN1A, CDKN2A	63	23	16792	23.17736369910283	1.0	0.41204679804377253	72.99535255734719
GAD_DISEASE	Carcinoma, Squamous Cell|Esophageal Neoplasms|Oesophageal neoplasm|Squamous cell carcinoma	2	3.1746031746031744	0.0843735122449823	CDKN1A, TP53	58	20	12971	22.363793103448277	1.0	0.5504766493017806	75.77538135428976
GAD_DISEASE	Myocardial Infarction	6	9.523809523809524	0.08566175424510367	CDKN2A, GADD45G, SERPINE1, IGF1, ATR, THBS1	58	536	12971	2.5034096757591353	1.0	0.5533555150117015	76.31780964801074
BBID	1.RBphosphoE2F	3	4.761904761904762	0.08588496963724875	CDKN1A, CDKN2A, TP53	15	14	388	5.542857142857144	0.9031672875366367	0.2285002518952759	52.117523117935185
UP_SEQ_FEATURE	domain:CARD	2	3.1746031746031744	0.0859036069572684	CASP9, APAF1	63	29	20063	21.96278051450465	0.9999999991850427	0.7080147748615436	68.45964986120623
UP_KEYWORDS	Ligase	4	6.349206349206349	0.08697536595804553	RFWD2, MDM2, SIAH1, RCHY1	63	347	20581	3.7657929646402266	0.999981890793073	0.3538758449337187	64.81433041525406
GOTERM_MF_DIRECT	GO:0001968~fibronectin binding	2	3.1746031746031744	0.08707190421101041	THBS1, IGFBP3	60	26	16881	21.642307692307693	0.9999996103050215	0.3605898298237402	66.79046305214307
GOTERM_BP_DIRECT	GO:0015949~nucleobase-containing small molecule interconversion	2	3.1746031746031744	0.08838995374575992	RRM2, RRM2B	63	25	16792	21.3231746031746	1.0	0.43612271881362863	75.90308383058463
GOTERM_BP_DIRECT	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	2	3.1746031746031744	0.08838995374575992	CDKN1A, PTEN	63	25	16792	21.3231746031746	1.0	0.43612271881362863	75.90308383058463
GOTERM_BP_DIRECT	GO:0034612~response to tumor necrosis factor	2	3.1746031746031744	0.08838995374575992	CASP3, CASP8	63	25	16792	21.3231746031746	1.0	0.43612271881362863	75.90308383058463
GOTERM_BP_DIRECT	GO:2001235~positive regulation of apoptotic signaling pathway	2	3.1746031746031744	0.08838995374575992	APAF1, PTEN	63	25	16792	21.3231746031746	1.0	0.43612271881362863	75.90308383058463
KEGG_PATHWAY	hsa05145:Toxoplasmosis	4	6.349206349206349	0.08899453256243933	CASP3, CASP9, CYCS, CASP8	63	118	6910	3.7180521926284635	0.9999488053896055	0.22894590415954386	64.86142339979271
INTERPRO	IPR001315:Caspase Recruitment	2	3.1746031746031744	0.08969717238149962	CASP9, APAF1	61	29	18559	20.98247597512719	0.9999994816449542	0.4394877697825882	67.6112946625189
UP_SEQ_FEATURE	sequence variant	45	71.42857142857143	0.09131838942956105	STEAP3, BID, CHEK1, CHEK2, RRM2B, SFN, CCNG1, SESN2, CCNG2, PTEN, SESN1, GTSE1, SESN3, CCNE2, CASP3, TP53I3, CDKN2A, CASP9, CASP8, SERPINE1, FAS, THBS1, CYCS, TP53, IGF1, CDK6, ATR, CDK4, ATM, CDK2, CCNB3, CDKN1A, TNFRSF10B, CCNB2, CCND3, SERPINB5, CCND2, BAX, CD82, TSC2, GADD45G, DDB2, MDM4, PERP, IGFBP3	63	12443	20063	1.1517089356034949	0.9999999997958566	0.7104903345924943	70.77744969543176
SMART	SM00005:DEATH	2	3.1746031746031744	0.09239688870945457	TNFRSF10B, FAS	37	27	10057	20.134134134134136	0.9550560507275165	0.32144679839554235	56.81384108067829
KEGG_PATHWAY	hsa04071:Sphingolipid signaling pathway	4	6.349206349206349	0.0924911528123771	BID, BAX, TP53, PTEN	63	120	6910	3.656084656084656	0.9999659441309948	0.23185922428542483	66.34545193283343
UP_SEQ_FEATURE	binding site:ATP	5	7.936507936507936	0.0937997855679909	CHEK1, CDK6, CHEK2, CDK4, CDK2	63	558	20063	2.8535870740171814	0.9999999998920484	0.7011638535433713	71.78621416850974
GOTERM_BP_DIRECT	GO:0043029~T cell homeostasis	2	3.1746031746031744	0.09511948250861818	CCNB2, PMAIP1	63	27	16792	19.74368018812463	1.0	0.45887301049394347	78.49801725511728
KEGG_PATHWAY	hsa04150:mTOR signaling pathway	3	4.761904761904762	0.09514004021059708	TSC2, IGF1, PTEN	63	58	6910	5.6732348111658455	0.9999750181078345	0.23274339950446699	67.43142798726855
KEGG_PATHWAY	hsa04650:Natural killer cell mediated cytotoxicity	4	6.349206349206349	0.09604473892347573	BID, CASP3, TNFRSF10B, FAS	63	122	6910	3.5961488420504812	0.9999775314372319	0.2297640453684463	67.79495418764195
GOTERM_BP_DIRECT	GO:0045931~positive regulation of mitotic cell cycle	2	3.1746031746031744	0.09846589420545414	CCNB1, MDM2	63	28	16792	19.038548752834465	1.0	0.46851290161705583	79.68883602270552
GAD_DISEASE	myocardial infarct	3	4.761904761904762	0.09895212888795506	CDKN2A, SERPINE1, THBS1	58	121	12971	5.544742091764036	1.0	0.6056444930750813	81.28715208176939
